MEK5
Normalized values from positional scanning peptide array
Phospho-serine (pS) is a duplicate of phospho-tyrosine (pT) in PSPA
Position-wise Probabilities
Log-Odds: Probabilities / STY Background
Sites with acceptor types representing >8% and count ≥10 are included
S Sites Probabilities
T Sites Probabilities
Y Sites Probabilities
Log-Odds: S Sites / S Background
Log-Odds: T Sites / T Background
Log-Odds: Y Sites / Y Background
Sites with acceptor types representing >8% and count ≥10 are included
Motif clusters with count ≥ 10 are shown
Download
| substrate_uniprot | site | source | substrate_genes | site_seq |
|---|---|---|---|---|
| A5A3E0 | T949 | Sugiyama | POTEF A26C1B | TVAsSSSLEKsyELPDGQVItIGNERFRCPEALFQPCFLGM |
| O95373 | T968 | Sugiyama | IPO7 RANBP7 | IIDDEDNPVDEYQIFKAIFQtIQNRNPVWyQALTHGLNEEQ |
| P00338 | T322 | Sugiyama | LDHA PIG19 | DLVKVTLtsEEEARLKKsADtLWGIQKELQF__________ |
| P00558 | T168 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | EAFRAsLSKLGDVyVNDAFGtAHRAHssMVGVNLPQKAGGF |
| P04075 | S36 | Sugiyama | ALDOA ALDA | LsDIAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENR |
| P04075 | S39 | Sugiyama | ALDOA ALDA | IAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENRRFy |
| P04075 | T37 | Sugiyama | ALDOA ALDA | sDIAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENRR |
| P04406 | S241 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | IPELNGKLtGMAFRVPtANVsVVDLtCRLEKPAKyDDIKKV |
| P04406 | T211 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | PsGKLWRDGRGALQNIIPAstGAAKAVGKVIPELNGKLtGM |
| P04406 | T246 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | GKLtGMAFRVPtANVsVVDLtCRLEKPAKyDDIKKVVKQAS |
| P04792 | S82 | Sugiyama | HSPB1 HSP27 HSP28 | AIEsPAVAAPAYsRALsRQLssGVsEIRHtADRWRVsLDVN |
| P06733 | S27 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | HAREIFDsRGNPtVEVDLFtsKGLFRAAVPsGAstGIyEAL |
| P06733 | S37 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | NPtVEVDLFtsKGLFRAAVPsGAstGIyEALELRDNDKtRY |
| P06733 | T205 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | GAEVyHNLKNVIKEKyGKDAtNVGDEGGFAPNILENKEGLE |
| P06733 | Y44 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | LFtsKGLFRAAVPsGAstGIyEALELRDNDKtRYMGKGVSK |
| P07195 | S303 | Sugiyama | LDHB | GIENEVFLSLPCILNARGLtsVINQKLKDDEVAQLKKsADt |
| P07195 | T323 | Sugiyama | LDHB | sVINQKLKDDEVAQLKKsADtLWDIQKDLKDL_________ |
| P07205 | T168 | Sugiyama | PGK2 PGKB | EAFRAsLSKLGDVyVNDAFGtAHRAHSSMVGVNLPHKASGF |
| P07737 | S30 | Sugiyama | PFN1 | NLMADGTCQDAAIVGYKDsPsVWAAVPGKtFVNITPAEVGV |
| P07900 | S263 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | EEKEKEEKEsEDKPEIEDVGsDEEEEKKDGDKKKKKKIKEK |
| P07900 | S52 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | LIINtFySNKEIFLRELIsNssDALDKIRyEsLtDPsKLDs |
| P09382 | T58 | Sugiyama | LGALS1 | DsNNLCLHFNPRFNAHGDANtIVCNsKDGGAWGTEQREAVF |
| P0DPH7 | T334 | Sugiyama | TUBA3C TUBA2 | ACCMLYRGDVVPKDVNAAIAtIKtKRTIQFVDWCPTGFKVG |
| P11142 | T163 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | VVtVPAyFNDsQRQAtKDAGtIAGLNVLRIINEPtAAAIAy |
| P11142 | T64 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | FtDtERLIGDAAKNQVAMNPtNtVFDAKRLIGRRFDDAVVQ |
| P11142 | T66 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | DtERLIGDAAKNQVAMNPtNtVFDAKRLIGRRFDDAVVQsD |
| P14618 | T50 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | MCRLDIDsPPItARNtGIICtIGPAsRsVEtLKEMIKsGMN |
| P25786 | T11 | Sugiyama | PSMA1 HC2 NU PROS30 PSC2 | __________MFRNQyDNDVtVWsPQGRIHQIEYAMEAVKQ |
| P26038 | S576 | Sugiyama | MSN | YKtLRQIRQGNTKQRIDEFEsM___________________ |
| P26373 | T148 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | PRKPSAPKKGDssAEELKLAtQLtGPVMPVRNVYKKEKARV |
| P26373 | T151 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | PSAPKKGDssAEELKLAtQLtGPVMPVRNVYKKEKARVItE |
| P27797 | T34 | Sugiyama | CALR CRTC | LAVAEPAVYFKEQFLDGDGWtsRWIEsKHKSDFGKFVLssG |
| P32969 | S182 | Sugiyama | RPL9 OK/SW-cl.103; RPL9P7; RPL9P8; RPL9P9 | QQATTVKNKDIRKFLDGIyVsEKGtVQQADE__________ |
| P32969 | Y180 | Sugiyama | RPL9 OK/SW-cl.103; RPL9P7; RPL9P8; RPL9P9 | LIQQATTVKNKDIRKFLDGIyVsEKGtVQQADE________ |
| P37802 | T180 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | RNFsDNQLQEGKNVIGLQMGtNRGAsQAGMtGyGMPRQIL_ |
| P38117 | T172 | Sugiyama | ETFB FP585 | QVTLEGDKLKVEREIDGGLEtLRLKLPAVVTADLRLNEPRy |
| P38646 | T116 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | DGERLVGMPAKRQAVtNPNNtFyAtKRLIGRRYDDPEVQKD |
| P38646 | T120 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | LVGMPAKRQAVtNPNNtFyAtKRLIGRRYDDPEVQKDIKNV |
| P38646 | T398 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | SDIGEVILVGGMTRMPKVQQtVQDLFGRAPsKAVNPDEAVA |
| P39019 | Y48 | Sugiyama | RPS19 | LKVPEWVDtVKLAKHKELAPyDENWFytRAAstARHLYLRG |
| P39019 | Y54 | Sugiyama | RPS19 | VDtVKLAKHKELAPyDENWFytRAAstARHLYLRGGAGVGs |
| P55854 | S27 | Sugiyama | SUMO3 SMT3A SMT3H1 | KEGVKTENDHINLKVAGQDGsVVQFKIKRHTPLSKLMKAYC |
| P60709 | S323 | Sugiyama | ACTB | ttMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGG |
| P60709 | T249 | Sugiyama | ACTB | tAAssssLEKsyELPDGQVItIGNERFRCPEALFQPsFLGM |
| P60709 | T324 | Sugiyama | ACTB | tMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGGs |
| P61254 | T8 | Sugiyama | RPL26 | _____________MKFNPFVtsDRsKNRKRHFNAPsHIRRK |
| P61956 | S28 | Sugiyama | SUMO2 SMT3B SMT3H2 | EGVKtENNDHINLKVAGQDGsVVQFKIKRHTPLSKLMKAYC |
| P62249 | S9 | Sugiyama | RPS16 | ____________MPsKGPLQsVQVFGRKKTATAVAHCKRGN |
| P62258 | S148 | Sugiyama | YWHAE | YHRyLAEFAtGNDRKEAAENsLVAyKAAsDIAMtELPPTHP |
| P62273 | Y7 | Sugiyama | RPS29 | ______________MGHQQLyWsHPRKFGQGSRSCRVCSNR |
| P62424 | T84 | Sugiyama | RPL7A SURF-3 SURF3 | QRQRAILyKRLKVPPAINQFtQALDRQTAtQLLKLAHKYRP |
| P62736 | S325 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | tTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P62736 | T251 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | tAAssssLEKsyELPDGQVItIGNERFRCPETLFQPSFIGM |
| P62736 | T326 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | TMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGGS |
| P62826 | T66 | Sugiyama | RAN ARA24 OK/SW-cl.81 | EVHPLVFHTNRGPIKFNVWDtAGQEKFGGLRDGYYIQAQCA |
| P62942 | T7 | Sugiyama | FKBP1A FKBP1 FKBP12 | ______________MGVQVEtIsPGDGRtFPKRGQtCVVHy |
| P63261 | S323 | Sugiyama | ACTG1 ACTG | ttMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGG |
| P63261 | T249 | Sugiyama | ACTG1 ACTG | tAAssssLEKsyELPDGQVItIGNERFRCPEALFQPsFLGM |
| P63261 | T324 | Sugiyama | ACTG1 ACTG | tMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGGs |
| P63267 | S324 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | tTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P63267 | T250 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | tAAssssLEKsyELPDGQVItIGNERFRCPETLFQPSFIGM |
| P63267 | T325 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | TMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGGS |
| P68032 | S325 | Sugiyama | ACTC1 ACTC | tTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P68032 | T251 | Sugiyama | ACTC1 ACTC | tAAssssLEKsyELPDGQVItIGNERFRCPETLFQPSFIGM |
| P68032 | T326 | Sugiyama | ACTC1 ACTC | TMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGGS |
| P68104 | T432 | Sugiyama | EEF1A1 EEF1A EF1A LENG7 | VEsFSDyPPLGRFAVRDMRQtVAVGVIKAVDKKAAGAGKVT |
| P68133 | S325 | Sugiyama | ACTA1 ACTA | TTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P68133 | T251 | Sugiyama | ACTA1 ACTA | tAAssssLEKsyELPDGQVItIGNERFRCPETLFQPSFIGM |
| P68133 | T326 | Sugiyama | ACTA1 ACTA | TMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGGS |
| P68363 | T334 | Sugiyama | TUBA1B | ACCLLyRGDVVPKDVNAAIAtIKtKRsIQFVDWCPTGFKVG |
| P68363 | Y432 | Sugiyama | TUBA1B | GMEEGEFSEAREDMAALEKDyEEVGVDsVEGEGEEEGEEy_ |
| Q05639 | T432 | Sugiyama | EEF1A2 EEF1AL STN | VESFSQYPPLGRFAVRDMRQtVAVGVIKNVEKKSGGAGKVT |
| Q07020 | T85 | Sugiyama | RPL18 | RMIRKMKLPGRENKtAVVVGtItDDVRVQEVPKLKVCALRV |
| Q13163 | S129 | Sugiyama | MAP2K5 MEK5 MKK5 PRKMK5 | CKPPGERNIHGLKVNtRAGPsQHssPAVsDsLPsNsLKKss |
| Q13163 | S132 | Sugiyama | MAP2K5 MEK5 MKK5 PRKMK5 | PGERNIHGLKVNtRAGPsQHssPAVsDsLPsNsLKKssAEL |
| Q13163 | S139 | Sugiyama | MAP2K5 MEK5 MKK5 PRKMK5 | GLKVNtRAGPsQHssPAVsDsLPsNsLKKssAELKKILANG |
| Q13163 | S142 | Sugiyama | MAP2K5 MEK5 MKK5 PRKMK5 | VNtRAGPsQHssPAVsDsLPsNsLKKssAELKKILANGQMN |
| Q13163 | S144 | Sugiyama | MAP2K5 MEK5 MKK5 PRKMK5 | tRAGPsQHssPAVsDsLPsNsLKKssAELKKILANGQMNEQ |
| Q13163 | T124 | Sugiyama | MAP2K5 MEK5 MKK5 PRKMK5 | IFPRACKPPGERNIHGLKVNtRAGPsQHssPAVsDsLPsNs |
| Q13163 | T171 | Sugiyama | MAP2K5 MEK5 MKK5 PRKMK5 | ELKKILANGQMNEQDIRYRDtLGHGNGGtVYKAYHVPSGKI |
| Q13163 | T179 | Sugiyama | MAP2K5 MEK5 MKK5 PRKMK5 | GQMNEQDIRYRDtLGHGNGGtVYKAYHVPSGKILAVKVILL |
| Q13163 | T319 | Sugiyama | MAP2K5 MEK5 MKK5 PRKMK5 | LCDFGVSTQLVNsIAKtyVGtNAyMAPERISGEQYGIHSDV |
| Q13163 | Y316 | Sugiyama | MAP2K5 MEK5 MKK5 PRKMK5 | QVKLCDFGVSTQLVNsIAKtyVGtNAyMAPERISGEQYGIH |
| Q13163 | Y322 | Sugiyama | MAP2K5 MEK5 MKK5 PRKMK5 | FGVSTQLVNsIAKtyVGtNAyMAPERISGEQYGIHSDVWSL |
| Q13164 | T219 | SIGNOR|EPSD|PSP | MAPK7 BMK1 ERK5 PRKM7 | GDFGMARGLCtsPAEHQYFMtEyVAtRWYRAPELMLSLHEY |
| Q13164 | Y221 | SIGNOR|EPSD|PSP | MAPK7 BMK1 ERK5 PRKM7 | FGMARGLCtsPAEHQYFMtEyVAtRWYRAPELMLSLHEYTQ |
| Q14568 | S52 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | LIINTFYSNKEIFLRELIsNssDALDKIWYESLTDPSKLDS |
| Q562R1 | T250 | Sugiyama | ACTBL2 | RAAAssSPERsyELPDGQVItIGNERFRCPEAIFQPSFLGI |
| Q5VTE0 | T432 | Sugiyama | EEF1A1P5 EEF1AL3 | VEsFSDyPPLGRFAVRDMRQtVAVGVIKAVDKKAAGAGKVT |
| Q6EEV6 | S28 | Sugiyama | SUMO4 SMT3H4 | EEVKTENNNHINLKVAGQDGsVVQFKIKRQTPLSKLMKAYC |
| Q6PEY2 | T334 | Sugiyama | TUBA3E | ACCMLYRGDVVPKDVNAAIAtIKtKRTIQFVDWCPTGFKVG |
| Q6S8J3 | T949 | Sugiyama | POTEE A26C1A POTE2 | tAAssssLEKsyELPDGQVItIGNERFRCPEALFQPCFLGM |
| Q71U36 | T334 | Sugiyama | TUBA1A TUBA3 | ACCLLyRGDVVPKDVNAAIAtIKtKRTIQFVDWCPTGFKVG |
| Q71U36 | Y432 | Sugiyama | TUBA1A TUBA3 | GMEEGEFSEAREDMAALEKDyEEVGVDsVEGEGEEEGEEy_ |
| Q86VQ1 | S223 | Sugiyama | GLCCI1 | QTPsCWAEEGAEKRSHQRsAsWGsADQLKEQIAKLRQQLQR |
| Q8NFD5 | S1744 | Sugiyama | ARID1B BAF250B DAN15 KIAA1235 OSA2 | ALDTINILLYDDSTVATFNLsQLSGFLELLVEYFRKCLIDI |
| Q8TAM6 | S280 | Sugiyama | ERMN KIAA1189 | TISYRKIRKGNTKQRIDEFEsMMHL________________ |
| Q99759 | S147 | Sugiyama | MAP3K3 MAPKKK3 MEKK3 | HNsssPHSGVSRQVRIKAsQsAGDINtIyQPPEPRsRHLsV |
| Q99759 | S166 | Sugiyama | MAP3K3 MAPKKK3 MEKK3 | QsAGDINtIyQPPEPRsRHLsVssQNPGRssPPPGYVPERQ |
| Q99759 | S176 | Sugiyama | MAP3K3 MAPKKK3 MEKK3 | QPPEPRsRHLsVssQNPGRssPPPGYVPERQQHIARQGSYT |
| Q99759 | S337 | Sugiyama | MAP3K3 MAPKKK3 MEKK3 | tNGENMGLAVQYLDPRGRLRsADsENALsVQERNVPTKsPs |
| Q99759 | S340 | Sugiyama | MAP3K3 MAPKKK3 MEKK3 | ENMGLAVQYLDPRGRLRsADsENALsVQERNVPTKsPsAPI |
| Q99759 | S345 | Sugiyama | MAP3K3 MAPKKK3 MEKK3 | AVQYLDPRGRLRsADsENALsVQERNVPTKsPsAPINWRRG |
| Q99759 | T153 | Sugiyama | MAP3K3 MAPKKK3 MEKK3 | HSGVSRQVRIKAsQsAGDINtIyQPPEPRsRHLsVssQNPG |
| Q9BQE3 | T334 | Sugiyama | TUBA1C TUBA6 | ACCLLyRGDVVPKDVNAAIAtIKtKRTIQFVDWCPTGFKVG |
| Q9BYX7 | T249 | Sugiyama | POTEKP ACTBL3 FKSG30 | MAASSSSVEKsyELPDGQVItIGNERFRCPEALFQPCFLGM |
| Q9NY27 | S311 | Sugiyama | PPP4R2 SBBI57 | CTRQHCtEEDEEEDEEEEEEsFMtsREMIPERKNQEKESDD |
| Q9NY27 | S315 | Sugiyama | PPP4R2 SBBI57 | HCtEEDEEEDEEEEEEsFMtsREMIPERKNQEKESDDALTV |
| Q9NY27 | T314 | Sugiyama | PPP4R2 SBBI57 | QHCtEEDEEEDEEEEEEsFMtsREMIPERKNQEKESDDALT |
| Q9UNX3 | T8 | Sugiyama | RPL26L1 RPL26P1 | _____________MKFNPFVtsDRsKNRKRHFNAPSHVRRK |
Site Promiscuity
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Signal Transduction | R-HSA-162582 | 3.967104e-11 | 10.402 | 1 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 1.198081e-08 | 7.922 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 5.461345e-08 | 7.263 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 1.666341e-07 | 6.778 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 2.048084e-07 | 6.689 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 8.268484e-07 | 6.083 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 9.173836e-07 | 6.037 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 4.909098e-06 | 5.309 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 5.310133e-06 | 5.275 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 5.429439e-06 | 5.265 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 5.759525e-06 | 5.240 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 6.521090e-06 | 5.186 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 7.112337e-06 | 5.148 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 1.173342e-05 | 4.931 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 2.170319e-05 | 4.663 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 2.465637e-05 | 4.608 | 0 | 0 |
| Immune System | R-HSA-168256 | 4.949832e-05 | 4.305 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 5.751053e-05 | 4.240 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 5.857195e-05 | 4.232 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 8.803390e-05 | 4.055 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 8.803390e-05 | 4.055 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 9.474494e-05 | 4.023 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 9.757527e-05 | 4.011 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 1.010647e-04 | 3.995 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 1.101786e-04 | 3.958 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 1.101786e-04 | 3.958 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 1.156413e-04 | 3.937 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 1.156413e-04 | 3.937 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 1.363629e-04 | 3.865 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 1.440277e-04 | 3.842 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 1.569639e-04 | 3.804 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 1.779406e-04 | 3.750 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 1.829314e-04 | 3.738 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 2.192134e-04 | 3.659 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 2.347502e-04 | 3.629 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 2.334859e-04 | 3.632 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 3.467327e-04 | 3.460 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 3.711418e-04 | 3.430 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 3.884001e-04 | 3.411 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 4.031543e-04 | 3.395 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 3.953617e-04 | 3.403 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 4.215348e-04 | 3.375 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 4.558143e-04 | 3.341 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 4.996203e-04 | 3.301 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 5.277740e-04 | 3.278 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 5.515597e-04 | 3.258 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 5.487692e-04 | 3.261 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 5.741992e-04 | 3.241 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 7.277141e-04 | 3.138 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 7.381568e-04 | 3.132 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 7.424994e-04 | 3.129 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 7.626462e-04 | 3.118 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 8.013462e-04 | 3.096 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 7.995301e-04 | 3.097 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 8.473726e-04 | 3.072 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 8.473726e-04 | 3.072 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 8.473726e-04 | 3.072 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 8.306894e-04 | 3.081 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 8.810157e-04 | 3.055 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 9.231819e-04 | 3.035 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 1.025902e-03 | 2.989 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 1.025902e-03 | 2.989 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 1.158598e-03 | 2.936 | 1 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 1.170784e-03 | 2.932 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 1.366992e-03 | 2.864 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 1.506575e-03 | 2.822 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 1.549170e-03 | 2.810 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 1.717291e-03 | 2.765 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 1.859378e-03 | 2.731 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 1.974917e-03 | 2.704 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 1.997303e-03 | 2.700 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 2.262187e-03 | 2.645 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 2.281578e-03 | 2.642 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 2.342988e-03 | 2.630 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 2.585051e-03 | 2.588 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 2.609893e-03 | 2.583 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 2.843028e-03 | 2.546 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 3.001084e-03 | 2.523 | 1 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 3.284724e-03 | 2.484 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 3.579607e-03 | 2.446 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 3.694613e-03 | 2.432 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 3.760774e-03 | 2.425 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 3.824563e-03 | 2.417 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 3.760774e-03 | 2.425 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 3.865027e-03 | 2.413 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 3.824563e-03 | 2.417 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 3.863607e-03 | 2.413 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 3.967304e-03 | 2.402 | 0 | 0 |
| Activation, translocation and oligomerization of BAX | R-HSA-114294 | 4.158163e-03 | 2.381 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 4.495990e-03 | 2.347 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 5.050722e-03 | 2.297 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 5.050722e-03 | 2.297 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 5.201509e-03 | 2.284 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 5.338671e-03 | 2.273 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 5.760168e-03 | 2.240 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 5.896852e-03 | 2.229 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 5.984904e-03 | 2.223 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 7.359926e-03 | 2.133 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 7.359926e-03 | 2.133 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 7.359926e-03 | 2.133 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 7.359926e-03 | 2.133 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 7.359926e-03 | 2.133 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 7.359926e-03 | 2.133 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 7.359926e-03 | 2.133 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 7.359926e-03 | 2.133 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 7.581380e-03 | 2.120 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 7.581380e-03 | 2.120 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 7.670996e-03 | 2.115 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 7.804199e-03 | 2.108 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 8.322882e-03 | 2.080 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 8.604192e-03 | 2.065 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 9.018442e-03 | 2.045 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 9.059118e-03 | 2.043 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 8.657201e-03 | 2.063 | 0 | 0 |
| TGFBR3 regulates FGF2 signaling | R-HSA-9839397 | 9.070343e-03 | 2.042 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 9.070343e-03 | 2.042 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 9.107496e-03 | 2.041 | 1 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 9.140566e-03 | 2.039 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 9.380295e-03 | 2.028 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 9.679084e-03 | 2.014 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 9.991185e-03 | 2.000 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 1.147301e-02 | 1.940 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 1.117986e-02 | 1.952 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 1.080866e-02 | 1.966 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 1.117444e-02 | 1.952 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 1.200532e-02 | 1.921 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 1.223205e-02 | 1.913 | 0 | 0 |
| Cation-coupled Chloride cotransporters | R-HSA-426117 | 1.223205e-02 | 1.913 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 1.263730e-02 | 1.898 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 1.283187e-02 | 1.892 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 1.306031e-02 | 1.884 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 1.312175e-02 | 1.882 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 1.418157e-02 | 1.848 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 1.464139e-02 | 1.834 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 1.415668e-02 | 1.849 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 1.453552e-02 | 1.838 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 1.453552e-02 | 1.838 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 1.397963e-02 | 1.855 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 1.458388e-02 | 1.836 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 1.493010e-02 | 1.826 | 0 | 0 |
| Regulation of TP53 Expression | R-HSA-6804754 | 1.563487e-02 | 1.806 | 0 | 0 |
| Stimulation of the cell death response by PAK-2p34 | R-HSA-211736 | 1.563487e-02 | 1.806 | 0 | 0 |
| Diseases of Cellular Senescence | R-HSA-9630747 | 1.563487e-02 | 1.806 | 0 | 0 |
| Diseases of cellular response to stress | R-HSA-9675132 | 1.563487e-02 | 1.806 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 1.573220e-02 | 1.803 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 1.573220e-02 | 1.803 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 1.724536e-02 | 1.763 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 1.724536e-02 | 1.763 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 1.724536e-02 | 1.763 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 1.661436e-02 | 1.780 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 1.553636e-02 | 1.809 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 1.603883e-02 | 1.795 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 1.561124e-02 | 1.807 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 1.663173e-02 | 1.779 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 1.721950e-02 | 1.764 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 1.586527e-02 | 1.800 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 1.663173e-02 | 1.779 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 1.675969e-02 | 1.776 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 1.815033e-02 | 1.741 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 1.821324e-02 | 1.740 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 1.821324e-02 | 1.740 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 1.837626e-02 | 1.736 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 1.973811e-02 | 1.705 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 1.973811e-02 | 1.705 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 1.973811e-02 | 1.705 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 1.973811e-02 | 1.705 | 0 | 0 |
| Axonal growth stimulation | R-HSA-209563 | 2.368981e-02 | 1.625 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 2.425387e-02 | 1.615 | 0 | 0 |
| Cross-presentation of particulate exogenous antigens (phagosomes) | R-HSA-1236973 | 2.425387e-02 | 1.615 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 2.425387e-02 | 1.615 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 2.425387e-02 | 1.615 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 2.396659e-02 | 1.620 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 2.438208e-02 | 1.613 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 2.477289e-02 | 1.606 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 2.530695e-02 | 1.597 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 2.546440e-02 | 1.594 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 2.579513e-02 | 1.588 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 2.624492e-02 | 1.581 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 2.624492e-02 | 1.581 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 2.776757e-02 | 1.556 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 2.776757e-02 | 1.556 | 0 | 0 |
| TNFR1-mediated ceramide production | R-HSA-5626978 | 3.308456e-02 | 1.480 | 0 | 0 |
| NADE modulates death signalling | R-HSA-205025 | 3.308456e-02 | 1.480 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 3.308456e-02 | 1.480 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 3.308456e-02 | 1.480 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 2.927944e-02 | 1.533 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 2.927944e-02 | 1.533 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 2.927944e-02 | 1.533 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 2.927944e-02 | 1.533 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 3.271408e-02 | 1.485 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 2.927944e-02 | 1.533 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 2.927944e-02 | 1.533 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 3.384474e-02 | 1.471 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 3.417410e-02 | 1.466 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 3.445983e-02 | 1.463 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 3.481123e-02 | 1.458 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 3.481123e-02 | 1.458 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 3.481123e-02 | 1.458 | 0 | 0 |
| Reduction of cytosolic Ca++ levels | R-HSA-418359 | 3.481123e-02 | 1.458 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 3.481123e-02 | 1.458 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 3.481123e-02 | 1.458 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 3.574783e-02 | 1.447 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 3.629902e-02 | 1.440 | 0 | 0 |
| IRS activation | R-HSA-74713 | 4.367922e-02 | 1.360 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 4.084245e-02 | 1.389 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 4.084245e-02 | 1.389 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 4.084245e-02 | 1.389 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 4.084245e-02 | 1.389 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 4.084245e-02 | 1.389 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 3.641711e-02 | 1.439 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 3.641711e-02 | 1.439 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 4.367922e-02 | 1.360 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 3.885437e-02 | 1.411 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 4.084245e-02 | 1.389 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 3.885437e-02 | 1.411 | 0 | 0 |
| SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes | R-HSA-111464 | 4.367922e-02 | 1.360 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 4.035046e-02 | 1.394 | 0 | 0 |
| Phosphorylation and nuclear translocation of BMAL1 (ARNTL) and CLOCK | R-HSA-9931529 | 4.367922e-02 | 1.360 | 0 | 0 |
| NFE2L2 regulating TCA cycle genes | R-HSA-9818025 | 4.367922e-02 | 1.360 | 0 | 0 |
| SMAC (DIABLO) binds to IAPs | R-HSA-111463 | 4.367922e-02 | 1.360 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 4.084245e-02 | 1.389 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 3.885437e-02 | 1.411 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 4.011166e-02 | 1.397 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 4.011166e-02 | 1.397 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 4.084245e-02 | 1.389 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 4.249431e-02 | 1.372 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 3.641711e-02 | 1.439 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 3.644817e-02 | 1.438 | 0 | 0 |
| NrCAM interactions | R-HSA-447038 | 4.367922e-02 | 1.360 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 3.835985e-02 | 1.416 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 4.459060e-02 | 1.351 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 4.459060e-02 | 1.351 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 4.459060e-02 | 1.351 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 4.459060e-02 | 1.351 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 4.459060e-02 | 1.351 | 0 | 0 |
| M Phase | R-HSA-68886 | 4.567834e-02 | 1.340 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to p14ARF Defects | R-HSA-9646304 | 4.598266e-02 | 1.337 | 0 | 0 |
| Defective translocation of RB1 mutants to the nucleus | R-HSA-9661070 | 4.598266e-02 | 1.337 | 0 | 0 |
| Loss of Function of TP53 in Cancer | R-HSA-9723907 | 4.598266e-02 | 1.337 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to p14ARF Defects | R-HSA-9646303 | 4.598266e-02 | 1.337 | 0 | 0 |
| Loss of function of TP53 in cancer due to loss of tetramerization ability | R-HSA-9723905 | 4.598266e-02 | 1.337 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 4.704810e-02 | 1.327 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 4.722221e-02 | 1.326 | 0 | 0 |
| CLEC7A/inflammasome pathway | R-HSA-5660668 | 5.534387e-02 | 1.257 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 5.534387e-02 | 1.257 | 0 | 0 |
| Activation of caspases through apoptosome-mediated cleavage | R-HSA-111459 | 5.534387e-02 | 1.257 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 4.736358e-02 | 1.325 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 4.736358e-02 | 1.325 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 5.493673e-02 | 1.260 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 5.493673e-02 | 1.260 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 5.460904e-02 | 1.263 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 5.904728e-02 | 1.229 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 5.666655e-02 | 1.247 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 5.534387e-02 | 1.257 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 5.904728e-02 | 1.229 | 0 | 0 |
| SMAC, XIAP-regulated apoptotic response | R-HSA-111469 | 5.534387e-02 | 1.257 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 5.534387e-02 | 1.257 | 0 | 0 |
| Release of apoptotic factors from the mitochondria | R-HSA-111457 | 5.534387e-02 | 1.257 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 4.736358e-02 | 1.325 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 5.460904e-02 | 1.263 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 4.792919e-02 | 1.319 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 5.666655e-02 | 1.247 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 5.534387e-02 | 1.257 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 5.009045e-02 | 1.300 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 5.980215e-02 | 1.223 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 6.005667e-02 | 1.221 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 6.114244e-02 | 1.214 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 6.182591e-02 | 1.209 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 6.182591e-02 | 1.209 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 6.268895e-02 | 1.203 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 6.320349e-02 | 1.199 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 6.368526e-02 | 1.196 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 6.624836e-02 | 1.179 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 6.795798e-02 | 1.168 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 6.795798e-02 | 1.168 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 6.829580e-02 | 1.166 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 6.852217e-02 | 1.164 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 6.943663e-02 | 1.158 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 6.973749e-02 | 1.157 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 6.973749e-02 | 1.157 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 7.113890e-02 | 1.148 | 0 | 0 |
| Drug-mediated inhibition of MET activation | R-HSA-9734091 | 8.985358e-02 | 1.046 | 0 | 0 |
| Regulation of PAK-2p34 activity by PS-GAP/RHG10 | R-HSA-211728 | 8.985358e-02 | 1.046 | 0 | 0 |
| Defective DNA double strand break response due to BRCA1 loss of function | R-HSA-9663199 | 8.985358e-02 | 1.046 | 0 | 0 |
| Defective DNA double strand break response due to BARD1 loss of function | R-HSA-9699150 | 8.985358e-02 | 1.046 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 | R-HSA-9632697 | 8.985358e-02 | 1.046 | 0 | 0 |
| TICAM1 deficiency - HSE | R-HSA-5602566 | 8.985358e-02 | 1.046 | 0 | 0 |
| Defective Mismatch Repair Associated With PMS2 | R-HSA-5632987 | 8.985358e-02 | 1.046 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 | R-HSA-9630791 | 8.985358e-02 | 1.046 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis Due to p14ARF Loss of Function | R-HSA-9645722 | 8.985358e-02 | 1.046 | 0 | 0 |
| Defective Mismatch Repair Associated With MLH1 | R-HSA-5545483 | 8.985358e-02 | 1.046 | 0 | 0 |
| Activated NTRK2 signals through CDK5 | R-HSA-9032845 | 8.140982e-02 | 1.089 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 8.140982e-02 | 1.089 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 8.140982e-02 | 1.089 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 8.140982e-02 | 1.089 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 8.140982e-02 | 1.089 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 9.559591e-02 | 1.020 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 9.559591e-02 | 1.020 | 0 | 0 |
| FGFR1b ligand binding and activation | R-HSA-190370 | 9.559591e-02 | 1.020 | 0 | 0 |
| Activation of RAS in B cells | R-HSA-1169092 | 9.559591e-02 | 1.020 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 9.216425e-02 | 1.035 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 8.421227e-02 | 1.075 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 7.553902e-02 | 1.122 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 7.483931e-02 | 1.126 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 9.464099e-02 | 1.024 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 8.479174e-02 | 1.072 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 8.296490e-02 | 1.081 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 9.559591e-02 | 1.020 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 8.421227e-02 | 1.075 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 7.355678e-02 | 1.133 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 7.272375e-02 | 1.138 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 9.216425e-02 | 1.035 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 8.721044e-02 | 1.059 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 9.194262e-02 | 1.036 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 8.565149e-02 | 1.067 | 0 | 0 |
| Activation and oligomerization of BAK protein | R-HSA-111452 | 8.985358e-02 | 1.046 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 9.014076e-02 | 1.045 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 7.884105e-02 | 1.103 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 7.355678e-02 | 1.133 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 7.355678e-02 | 1.133 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 7.878749e-02 | 1.104 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 8.306362e-02 | 1.081 | 0 | 0 |
| Formation of editosomes by ADAR proteins | R-HSA-77042 | 8.985358e-02 | 1.046 | 0 | 0 |
| SDK interactions | R-HSA-373756 | 8.985358e-02 | 1.046 | 0 | 0 |
| Inhibition of PKR | R-HSA-169131 | 8.985358e-02 | 1.046 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 8.528682e-02 | 1.069 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 8.658458e-02 | 1.063 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 8.032264e-02 | 1.095 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 8.964242e-02 | 1.047 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 7.884105e-02 | 1.103 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 7.463257e-02 | 1.127 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 9.149230e-02 | 1.039 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 9.194262e-02 | 1.036 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 7.878749e-02 | 1.104 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 7.172140e-02 | 1.144 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 7.232311e-02 | 1.141 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 7.232311e-02 | 1.141 | 0 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 8.140982e-02 | 1.089 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 9.559591e-02 | 1.020 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 9.499384e-02 | 1.022 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 7.884105e-02 | 1.103 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 7.878749e-02 | 1.104 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 8.367854e-02 | 1.077 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 8.161298e-02 | 1.088 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 9.563424e-02 | 1.019 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 9.598548e-02 | 1.018 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 9.598548e-02 | 1.018 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 9.598548e-02 | 1.018 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 9.606416e-02 | 1.017 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 9.694071e-02 | 1.013 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 9.850636e-02 | 1.007 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 9.955951e-02 | 1.002 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 9.978596e-02 | 1.001 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 1.016256e-01 | 0.993 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 1.016256e-01 | 0.993 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 1.036302e-01 | 0.985 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 1.049102e-01 | 0.979 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to p16INK4A Defects | R-HSA-9632693 | 1.317096e-01 | 0.880 | 0 | 0 |
| NFG and proNGF binds to p75NTR | R-HSA-205017 | 1.317096e-01 | 0.880 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to p16INK4A Defects | R-HSA-9630750 | 1.317096e-01 | 0.880 | 0 | 0 |
| Defective SLC4A4 causes renal tubular acidosis, proximal, with ocular abnormalities and mental retardation (pRTA-OA) | R-HSA-5619054 | 1.317096e-01 | 0.880 | 0 | 0 |
| TRAF3 deficiency - HSE | R-HSA-5602571 | 1.317096e-01 | 0.880 | 0 | 0 |
| XAV939 stabilizes AXIN | R-HSA-5545619 | 1.317096e-01 | 0.880 | 0 | 0 |
| Defective PGM1 causes PGM1-CDG | R-HSA-5609974 | 1.317096e-01 | 0.880 | 0 | 0 |
| Signaling by TCF7L2 mutants | R-HSA-5339700 | 1.317096e-01 | 0.880 | 0 | 0 |
| Defective SLC20A2 causes idiopathic basal ganglia calcification 1 (IBGC1) | R-HSA-5619111 | 1.317096e-01 | 0.880 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6 | R-HSA-9632700 | 1.317096e-01 | 0.880 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6 | R-HSA-9630794 | 1.317096e-01 | 0.880 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 1.104205e-01 | 0.957 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 1.104205e-01 | 0.957 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 1.104205e-01 | 0.957 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 1.257950e-01 | 0.900 | 0 | 0 |
| Activation of Ca-permeable Kainate Receptor | R-HSA-451308 | 1.257950e-01 | 0.900 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 1.416378e-01 | 0.849 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 1.416378e-01 | 0.849 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 1.416378e-01 | 0.849 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 1.578733e-01 | 0.802 | 0 | 0 |
| ERKs are inactivated | R-HSA-202670 | 1.578733e-01 | 0.802 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 1.255921e-01 | 0.901 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 1.255921e-01 | 0.901 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 1.361105e-01 | 0.866 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 1.361105e-01 | 0.866 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 1.142973e-01 | 0.942 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 1.221496e-01 | 0.913 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 1.221496e-01 | 0.913 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 1.557040e-01 | 0.808 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 1.557851e-01 | 0.807 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 1.361641e-01 | 0.866 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 1.254576e-01 | 0.902 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 1.254576e-01 | 0.902 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 1.466925e-01 | 0.834 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 1.141523e-01 | 0.943 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 1.077996e-01 | 0.967 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 1.104205e-01 | 0.957 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 1.302254e-01 | 0.885 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 1.173532e-01 | 0.931 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 1.257950e-01 | 0.900 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 1.578733e-01 | 0.802 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 1.142973e-01 | 0.942 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 1.257950e-01 | 0.900 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 1.361105e-01 | 0.866 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 1.470119e-01 | 0.833 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 1.459703e-01 | 0.836 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 1.255921e-01 | 0.901 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 1.151973e-01 | 0.939 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 1.077996e-01 | 0.967 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 1.053959e-01 | 0.977 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 1.257950e-01 | 0.900 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 1.055084e-01 | 0.977 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 1.221496e-01 | 0.913 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 1.095977e-01 | 0.960 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 1.075737e-01 | 0.968 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 1.289532e-01 | 0.890 | 0 | 0 |
| Manipulation of host energy metabolism | R-HSA-9636667 | 1.317096e-01 | 0.880 | 0 | 0 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 1.257950e-01 | 0.900 | 0 | 0 |
| Ionotropic activity of kainate receptors | R-HSA-451306 | 1.416378e-01 | 0.849 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 1.578733e-01 | 0.802 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 1.484512e-01 | 0.828 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 1.470119e-01 | 0.833 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 1.153843e-01 | 0.938 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 1.302254e-01 | 0.885 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 1.217926e-01 | 0.914 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 1.361641e-01 | 0.866 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 1.160811e-01 | 0.935 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 1.249851e-01 | 0.903 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 1.104205e-01 | 0.957 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 1.208292e-01 | 0.918 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 1.178844e-01 | 0.929 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 1.217926e-01 | 0.914 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 1.217926e-01 | 0.914 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 1.578733e-01 | 0.802 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 1.142973e-01 | 0.942 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 1.124479e-01 | 0.949 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 1.104205e-01 | 0.957 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 1.257950e-01 | 0.900 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 1.055084e-01 | 0.977 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 1.267540e-01 | 0.897 | 0 | 0 |
| NTRK3 as a dependence receptor | R-HSA-9603505 | 1.317096e-01 | 0.880 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 1.578733e-01 | 0.802 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 1.558670e-01 | 0.807 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 1.416378e-01 | 0.849 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 1.578733e-01 | 0.802 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 1.221821e-01 | 0.913 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 1.104205e-01 | 0.957 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 1.055084e-01 | 0.977 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 1.257950e-01 | 0.900 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 1.083326e-01 | 0.965 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 1.579933e-01 | 0.801 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 1.632652e-01 | 0.787 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 1.645826e-01 | 0.784 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 1.654197e-01 | 0.781 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 1.654197e-01 | 0.781 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 1.690427e-01 | 0.772 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 1.693150e-01 | 0.771 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 1.693150e-01 | 0.771 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 1.716432e-01 | 0.765 | 0 | 0 |
| Activation, myristolyation of BID and translocation to mitochondria | R-HSA-75108 | 1.716432e-01 | 0.765 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 1.716432e-01 | 0.765 | 0 | 0 |
| Signalling to ERK5 | R-HSA-198765 | 1.716432e-01 | 0.765 | 1 | 1 |
| Interaction between PHLDA1 and AURKA | R-HSA-8854521 | 1.716432e-01 | 0.765 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 1.716432e-01 | 0.765 | 0 | 0 |
| Potassium transport channels | R-HSA-1296067 | 1.716432e-01 | 0.765 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 1.716432e-01 | 0.765 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 1.716432e-01 | 0.765 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 1.716432e-01 | 0.765 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 1.716432e-01 | 0.765 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 1.716432e-01 | 0.765 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 1.716432e-01 | 0.765 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 1.716432e-01 | 0.765 | 0 | 0 |
| Defective SLC12A1 causes Bartter syndrome 1 (BS1) | R-HSA-5619104 | 1.716432e-01 | 0.765 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 1.716432e-01 | 0.765 | 0 | 0 |
| mRNA Editing: A to I Conversion | R-HSA-75064 | 1.716432e-01 | 0.765 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 1.716432e-01 | 0.765 | 0 | 0 |
| C6 deamination of adenosine | R-HSA-75102 | 1.716432e-01 | 0.765 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 1.736380e-01 | 0.760 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 1.736380e-01 | 0.760 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 1.744321e-01 | 0.758 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 1.744321e-01 | 0.758 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 1.744321e-01 | 0.758 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 1.744321e-01 | 0.758 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 2.097425e-01 | 0.678 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 2.097425e-01 | 0.678 | 0 | 0 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 2.097425e-01 | 0.678 | 0 | 0 |
| MET activates PTPN11 | R-HSA-8865999 | 2.097425e-01 | 0.678 | 0 | 0 |
| Defective GCLC causes HAGGSD | R-HSA-5578999 | 2.097425e-01 | 0.678 | 0 | 0 |
| TLR3-mediated TICAM1-dependent programmed cell death | R-HSA-9013957 | 2.460917e-01 | 0.609 | 0 | 0 |
| Defective PNP disrupts phosphorolysis of (deoxy)guanosine and (deoxy)inosine | R-HSA-9735763 | 2.460917e-01 | 0.609 | 0 | 0 |
| AKT-mediated inactivation of FOXO1A | R-HSA-211163 | 2.460917e-01 | 0.609 | 0 | 0 |
| RUNX3 regulates BCL2L11 (BIM) transcription | R-HSA-8952158 | 2.460917e-01 | 0.609 | 0 | 0 |
| Nucleotide catabolism defects | R-HSA-9735786 | 2.460917e-01 | 0.609 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 2.460917e-01 | 0.609 | 0 | 0 |
| Abnormal conversion of 2-oxoglutarate to 2-hydroxyglutarate | R-HSA-2978092 | 2.460917e-01 | 0.609 | 0 | 0 |
| Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes | R-HSA-69200 | 2.460917e-01 | 0.609 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 2.807710e-01 | 0.552 | 0 | 0 |
| NOSIP mediated eNOS trafficking | R-HSA-203754 | 2.807710e-01 | 0.552 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 2.807710e-01 | 0.552 | 0 | 0 |
| Plus-strand DNA synthesis | R-HSA-164525 | 3.138571e-01 | 0.503 | 0 | 0 |
| PTK6 Regulates Cell Cycle | R-HSA-8849470 | 3.138571e-01 | 0.503 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 3.138571e-01 | 0.503 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 3.138571e-01 | 0.503 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 3.138571e-01 | 0.503 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 3.138571e-01 | 0.503 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 1.912502e-01 | 0.718 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 1.912502e-01 | 0.718 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 1.912502e-01 | 0.718 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 2.082690e-01 | 0.681 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 2.082690e-01 | 0.681 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 3.454231e-01 | 0.462 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 3.454231e-01 | 0.462 | 0 | 0 |
| Uncoating of the HIV Virion | R-HSA-162585 | 3.454231e-01 | 0.462 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 2.254344e-01 | 0.647 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 2.254344e-01 | 0.647 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 2.254344e-01 | 0.647 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 2.254344e-01 | 0.647 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 2.426972e-01 | 0.615 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 2.600120e-01 | 0.585 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 2.045487e-01 | 0.689 | 0 | 0 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 2.045487e-01 | 0.689 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 2.773377e-01 | 0.557 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 2.166478e-01 | 0.664 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 2.288910e-01 | 0.640 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 2.288910e-01 | 0.640 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 2.288910e-01 | 0.640 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 2.288910e-01 | 0.640 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 1.828603e-01 | 0.738 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 3.118749e-01 | 0.506 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 2.114285e-01 | 0.675 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 3.290213e-01 | 0.483 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 3.290213e-01 | 0.483 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 3.290213e-01 | 0.483 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 3.290213e-01 | 0.483 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 3.290213e-01 | 0.483 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 3.290213e-01 | 0.483 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 1.786419e-01 | 0.748 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 2.662973e-01 | 0.575 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 1.865272e-01 | 0.729 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 2.411378e-01 | 0.618 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 2.411378e-01 | 0.618 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 1.858980e-01 | 0.731 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 2.192450e-01 | 0.659 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 3.043469e-01 | 0.517 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 3.298536e-01 | 0.482 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 3.134041e-01 | 0.504 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 3.239264e-01 | 0.490 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 3.239264e-01 | 0.490 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 3.071526e-01 | 0.513 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 2.721074e-01 | 0.565 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 3.372489e-01 | 0.472 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 3.170964e-01 | 0.499 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 2.288910e-01 | 0.640 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 2.412593e-01 | 0.618 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 3.460480e-01 | 0.461 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 3.460480e-01 | 0.461 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 3.170964e-01 | 0.499 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 2.721074e-01 | 0.565 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 2.773377e-01 | 0.557 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 2.773377e-01 | 0.557 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 2.412593e-01 | 0.618 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 2.220421e-01 | 0.654 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 2.789316e-01 | 0.555 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 2.537341e-01 | 0.596 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 3.054791e-01 | 0.515 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 1.865272e-01 | 0.729 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 2.641115e-01 | 0.578 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 2.427283e-01 | 0.615 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 3.057337e-01 | 0.515 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 3.290213e-01 | 0.483 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 3.290213e-01 | 0.483 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 2.638406e-01 | 0.579 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 2.614450e-01 | 0.583 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 3.426045e-01 | 0.465 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 3.043469e-01 | 0.517 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 3.460480e-01 | 0.461 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 2.000730e-01 | 0.699 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 1.958572e-01 | 0.708 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 2.254344e-01 | 0.647 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 2.537341e-01 | 0.596 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 1.922395e-01 | 0.716 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 1.849654e-01 | 0.733 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 1.849654e-01 | 0.733 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 2.447616e-01 | 0.611 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 1.879894e-01 | 0.726 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 1.789635e-01 | 0.747 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 3.134041e-01 | 0.504 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 2.311246e-01 | 0.636 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 1.906665e-01 | 0.720 | 0 | 0 |
| SLC15A4:TASL-dependent IRF5 activation | R-HSA-9860276 | 3.138571e-01 | 0.503 | 0 | 0 |
| FGFR1c ligand binding and activation | R-HSA-190373 | 1.912502e-01 | 0.718 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 2.946367e-01 | 0.531 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 3.460480e-01 | 0.461 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 2.085752e-01 | 0.681 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 2.426972e-01 | 0.615 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 1.912502e-01 | 0.718 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 1.945361e-01 | 0.711 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 1.927533e-01 | 0.715 | 0 | 0 |
| Transcriptional activation of cell cycle inhibitor p21 | R-HSA-69895 | 2.460917e-01 | 0.609 | 0 | 0 |
| Transcriptional activation of p53 responsive genes | R-HSA-69560 | 2.460917e-01 | 0.609 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 3.138571e-01 | 0.503 | 0 | 0 |
| MET Receptor Activation | R-HSA-6806942 | 3.454231e-01 | 0.462 | 0 | 0 |
| Lysosphingolipid and LPA receptors | R-HSA-419408 | 2.254344e-01 | 0.647 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 2.426972e-01 | 0.615 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 3.426045e-01 | 0.465 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 3.290696e-01 | 0.483 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 2.123371e-01 | 0.673 | 0 | 0 |
| FGFR1 ligand binding and activation | R-HSA-190242 | 2.946367e-01 | 0.531 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 2.412593e-01 | 0.618 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 2.916202e-01 | 0.535 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 2.041599e-01 | 0.690 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 2.820620e-01 | 0.550 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 2.820620e-01 | 0.550 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 2.760265e-01 | 0.559 | 0 | 0 |
| MET activates STAT3 | R-HSA-8875791 | 2.097425e-01 | 0.678 | 0 | 0 |
| Activation of BIM and translocation to mitochondria | R-HSA-111446 | 2.097425e-01 | 0.678 | 0 | 0 |
| Dopamine receptors | R-HSA-390651 | 2.460917e-01 | 0.609 | 0 | 0 |
| Ceramide signalling | R-HSA-193681 | 3.138571e-01 | 0.503 | 0 | 0 |
| NADPH regeneration | R-HSA-389542 | 3.454231e-01 | 0.462 | 0 | 0 |
| Intracellular metabolism of fatty acids regulates insulin secretion | R-HSA-434313 | 3.454231e-01 | 0.462 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 2.254344e-01 | 0.647 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 2.045487e-01 | 0.689 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 3.043469e-01 | 0.517 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 2.431754e-01 | 0.614 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 2.946367e-01 | 0.531 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 1.831377e-01 | 0.737 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 2.300408e-01 | 0.638 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 3.344751e-01 | 0.476 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 2.000730e-01 | 0.699 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 1.808620e-01 | 0.743 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 2.052183e-01 | 0.688 | 0 | 0 |
| Activation of NOXA and translocation to mitochondria | R-HSA-111448 | 2.460917e-01 | 0.609 | 0 | 0 |
| Muscarinic acetylcholine receptors | R-HSA-390648 | 2.807710e-01 | 0.552 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 2.717196e-01 | 0.566 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 3.170964e-01 | 0.499 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 2.820620e-01 | 0.550 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 3.253938e-01 | 0.488 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 2.371119e-01 | 0.625 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 3.239264e-01 | 0.490 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 3.450314e-01 | 0.462 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 1.808620e-01 | 0.743 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 2.371119e-01 | 0.625 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 3.162566e-01 | 0.500 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 2.311246e-01 | 0.636 | 0 | 0 |
| Diseases of Mismatch Repair (MMR) | R-HSA-5423599 | 2.097425e-01 | 0.678 | 0 | 0 |
| Intracellular oxygen transport | R-HSA-8981607 | 2.097425e-01 | 0.678 | 0 | 0 |
| CASP5-mediated substrate cleavage | R-HSA-9960525 | 2.097425e-01 | 0.678 | 0 | 0 |
| p75NTR negatively regulates cell cycle via SC1 | R-HSA-193670 | 2.460917e-01 | 0.609 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 3.138571e-01 | 0.503 | 0 | 0 |
| Abacavir transmembrane transport | R-HSA-2161517 | 3.454231e-01 | 0.462 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 2.789316e-01 | 0.555 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 3.523020e-01 | 0.453 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 2.412593e-01 | 0.618 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 2.374073e-01 | 0.625 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 2.921982e-01 | 0.534 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 1.792511e-01 | 0.747 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 3.170964e-01 | 0.499 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 3.118749e-01 | 0.506 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 3.231428e-01 | 0.491 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 2.946367e-01 | 0.531 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 2.512479e-01 | 0.600 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 2.411378e-01 | 0.618 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 3.043469e-01 | 0.517 | 0 | 0 |
| CASP4-mediated substrate cleavage | R-HSA-9960519 | 2.097425e-01 | 0.678 | 0 | 0 |
| FLT3 signaling through SRC family kinases | R-HSA-9706374 | 2.460917e-01 | 0.609 | 0 | 0 |
| RUNX2 regulates chondrocyte maturation | R-HSA-8941284 | 2.807710e-01 | 0.552 | 0 | 0 |
| Sodium-coupled phosphate cotransporters | R-HSA-427652 | 3.138571e-01 | 0.503 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 2.082690e-01 | 0.681 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 2.045487e-01 | 0.689 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 3.290213e-01 | 0.483 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 2.085752e-01 | 0.681 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 2.460128e-01 | 0.609 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 3.460480e-01 | 0.461 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 2.181781e-01 | 0.661 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 2.537341e-01 | 0.596 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 3.290213e-01 | 0.483 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 3.253938e-01 | 0.488 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 3.222864e-01 | 0.492 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 3.298536e-01 | 0.482 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 2.709903e-01 | 0.567 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 3.162566e-01 | 0.500 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 2.789316e-01 | 0.555 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 2.717196e-01 | 0.566 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 2.807710e-01 | 0.552 | 0 | 0 |
| Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660825 | 3.138571e-01 | 0.503 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 3.138571e-01 | 0.503 | 0 | 0 |
| Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660826 | 3.138571e-01 | 0.503 | 0 | 0 |
| VLDL assembly | R-HSA-8866423 | 3.454231e-01 | 0.462 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 3.454231e-01 | 0.462 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 2.254344e-01 | 0.647 | 0 | 0 |
| Synthesis of PG | R-HSA-1483148 | 2.600120e-01 | 0.585 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 3.290213e-01 | 0.483 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 2.789316e-01 | 0.555 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 2.362256e-01 | 0.627 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 2.311246e-01 | 0.636 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 3.290213e-01 | 0.483 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 2.789316e-01 | 0.555 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 3.170964e-01 | 0.499 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 1.789635e-01 | 0.747 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 2.143647e-01 | 0.669 | 0 | 0 |
| RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs) | R-HSA-8877330 | 1.912502e-01 | 0.718 | 0 | 0 |
| TYSND1 cleaves peroxisomal proteins | R-HSA-9033500 | 3.138571e-01 | 0.503 | 0 | 0 |
| Neurofascin interactions | R-HSA-447043 | 3.454231e-01 | 0.462 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 1.926134e-01 | 0.715 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 2.946367e-01 | 0.531 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 3.118749e-01 | 0.506 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 2.212182e-01 | 0.655 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 2.713347e-01 | 0.566 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 3.298536e-01 | 0.482 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation | R-HSA-2892247 | 2.600120e-01 | 0.585 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 3.298536e-01 | 0.482 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 3.118749e-01 | 0.506 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 3.043469e-01 | 0.517 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 1.912502e-01 | 0.718 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 3.491169e-01 | 0.457 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 2.655092e-01 | 0.576 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 3.529481e-01 | 0.452 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 3.532111e-01 | 0.452 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 3.541398e-01 | 0.451 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 3.549273e-01 | 0.450 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 3.553357e-01 | 0.449 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 3.553357e-01 | 0.449 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 3.629296e-01 | 0.440 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 3.629296e-01 | 0.440 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 3.629296e-01 | 0.440 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 3.656471e-01 | 0.437 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 3.661051e-01 | 0.436 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 3.680341e-01 | 0.434 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 3.680341e-01 | 0.434 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 3.680341e-01 | 0.434 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 3.680341e-01 | 0.434 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 3.682051e-01 | 0.434 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 3.713816e-01 | 0.430 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 3.755387e-01 | 0.425 | 0 | 0 |
| MET activates PI3K/AKT signaling | R-HSA-8851907 | 3.755387e-01 | 0.425 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 3.755387e-01 | 0.425 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 3.755387e-01 | 0.425 | 0 | 0 |
| PP2A-mediated dephosphorylation of key metabolic factors | R-HSA-163767 | 3.755387e-01 | 0.425 | 0 | 0 |
| TRIF-mediated programmed cell death | R-HSA-2562578 | 3.755387e-01 | 0.425 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 3.755387e-01 | 0.425 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 3.755387e-01 | 0.425 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 3.755387e-01 | 0.425 | 0 | 0 |
| Synthesis of PIPs in the nucleus | R-HSA-8847453 | 3.755387e-01 | 0.425 | 0 | 0 |
| LDL remodeling | R-HSA-8964041 | 3.755387e-01 | 0.425 | 0 | 0 |
| TGFBR3 regulates TGF-beta signaling | R-HSA-9839389 | 3.755387e-01 | 0.425 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 3.755387e-01 | 0.425 | 0 | 0 |
| Phase 3 - rapid repolarisation | R-HSA-5576890 | 3.755387e-01 | 0.425 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 3.796437e-01 | 0.421 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 3.796437e-01 | 0.421 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 3.796437e-01 | 0.421 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 3.796437e-01 | 0.421 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 3.796437e-01 | 0.421 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 3.796437e-01 | 0.421 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 3.806877e-01 | 0.419 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 3.806877e-01 | 0.419 | 0 | 0 |
| S Phase | R-HSA-69242 | 3.813653e-01 | 0.419 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 3.825823e-01 | 0.417 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 3.872579e-01 | 0.412 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 3.904998e-01 | 0.408 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 3.932850e-01 | 0.405 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 3.932850e-01 | 0.405 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 3.945571e-01 | 0.404 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 3.961698e-01 | 0.402 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 3.961698e-01 | 0.402 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 3.961698e-01 | 0.402 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 3.962933e-01 | 0.402 | 0 | 0 |
| Reverse Transcription of HIV RNA | R-HSA-162589 | 4.042705e-01 | 0.393 | 0 | 0 |
| Minus-strand DNA synthesis | R-HSA-164516 | 4.042705e-01 | 0.393 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 4.042705e-01 | 0.393 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 4.042705e-01 | 0.393 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 4.042705e-01 | 0.393 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 4.042705e-01 | 0.393 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 4.042705e-01 | 0.393 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 4.042705e-01 | 0.393 | 0 | 0 |
| BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members | R-HSA-111453 | 4.042705e-01 | 0.393 | 0 | 0 |
| TGFBR3 PTM regulation | R-HSA-9839383 | 4.042705e-01 | 0.393 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 4.042705e-01 | 0.393 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 4.042705e-01 | 0.393 | 0 | 0 |
| Sodium/Proton exchangers | R-HSA-425986 | 4.042705e-01 | 0.393 | 0 | 0 |
| Interleukin-23 signaling | R-HSA-9020933 | 4.042705e-01 | 0.393 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 4.051253e-01 | 0.392 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 4.058149e-01 | 0.392 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 4.058149e-01 | 0.392 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 4.058149e-01 | 0.392 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 4.082591e-01 | 0.389 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 4.082591e-01 | 0.389 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 4.124899e-01 | 0.385 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 4.124899e-01 | 0.385 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 4.143462e-01 | 0.383 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 4.182673e-01 | 0.379 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 4.182673e-01 | 0.379 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 4.182673e-01 | 0.379 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 4.187073e-01 | 0.378 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 4.205175e-01 | 0.376 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 4.205175e-01 | 0.376 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 4.235880e-01 | 0.373 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 4.280878e-01 | 0.368 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 4.285881e-01 | 0.368 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 4.285881e-01 | 0.368 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 4.285881e-01 | 0.368 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 4.306324e-01 | 0.366 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 4.306324e-01 | 0.366 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 4.316821e-01 | 0.365 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 4.316821e-01 | 0.365 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 4.316821e-01 | 0.365 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 4.316821e-01 | 0.365 | 0 | 0 |
| mRNA Editing | R-HSA-75072 | 4.316821e-01 | 0.365 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 4.316821e-01 | 0.365 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 4.316821e-01 | 0.365 | 0 | 0 |
| Regulation of signaling by NODAL | R-HSA-1433617 | 4.316821e-01 | 0.365 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 4.316821e-01 | 0.365 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 4.316821e-01 | 0.365 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 4.316821e-01 | 0.365 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 4.316821e-01 | 0.365 | 0 | 0 |
| Interleukin-1 processing | R-HSA-448706 | 4.316821e-01 | 0.365 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 4.316821e-01 | 0.365 | 0 | 0 |
| Zinc influx into cells by the SLC39 gene family | R-HSA-442380 | 4.316821e-01 | 0.365 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 4.318278e-01 | 0.365 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 4.321289e-01 | 0.364 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 4.356461e-01 | 0.361 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 4.375324e-01 | 0.359 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 4.394672e-01 | 0.357 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 4.400480e-01 | 0.356 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 4.429013e-01 | 0.354 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 4.444502e-01 | 0.352 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 4.444502e-01 | 0.352 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 4.444502e-01 | 0.352 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 4.444502e-01 | 0.352 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 4.444502e-01 | 0.352 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 4.444502e-01 | 0.352 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 4.447449e-01 | 0.352 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 4.455356e-01 | 0.351 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 4.550655e-01 | 0.342 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 4.550655e-01 | 0.342 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 4.550655e-01 | 0.342 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 4.557914e-01 | 0.341 | 0 | 0 |
| Binding and entry of HIV virion | R-HSA-173107 | 4.578339e-01 | 0.339 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 4.578339e-01 | 0.339 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 4.578339e-01 | 0.339 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 4.578339e-01 | 0.339 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 4.578339e-01 | 0.339 | 0 | 0 |
| Regulation of the apoptosome activity | R-HSA-9627069 | 4.578339e-01 | 0.339 | 0 | 0 |
| Formation of apoptosome | R-HSA-111458 | 4.578339e-01 | 0.339 | 0 | 0 |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | R-HSA-5140745 | 4.578339e-01 | 0.339 | 0 | 0 |
| Formation of intermediate mesoderm | R-HSA-9761174 | 4.578339e-01 | 0.339 | 0 | 0 |
| Maturation of spike protein | R-HSA-9683686 | 4.578339e-01 | 0.339 | 0 | 0 |
| Metal sequestration by antimicrobial proteins | R-HSA-6799990 | 4.578339e-01 | 0.339 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 4.578915e-01 | 0.339 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 4.595188e-01 | 0.338 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 4.595188e-01 | 0.338 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 4.595188e-01 | 0.338 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 4.600639e-01 | 0.337 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 4.600639e-01 | 0.337 | 0 | 0 |
| Triglyceride biosynthesis | R-HSA-75109 | 4.600639e-01 | 0.337 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 4.600639e-01 | 0.337 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 4.600639e-01 | 0.337 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 4.657102e-01 | 0.332 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 4.671170e-01 | 0.331 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 4.671170e-01 | 0.331 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 4.731717e-01 | 0.325 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 4.731717e-01 | 0.325 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 4.754184e-01 | 0.323 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 4.754184e-01 | 0.323 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 4.754184e-01 | 0.323 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 4.754184e-01 | 0.323 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 4.756205e-01 | 0.323 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 4.790486e-01 | 0.320 | 0 | 0 |
| Presynaptic depolarization and calcium channel opening | R-HSA-112308 | 4.827838e-01 | 0.316 | 0 | 0 |
| FGFR2b ligand binding and activation | R-HSA-190377 | 4.827838e-01 | 0.316 | 0 | 0 |
| FGFRL1 modulation of FGFR1 signaling | R-HSA-5658623 | 4.827838e-01 | 0.316 | 0 | 0 |
| Chylomicron assembly | R-HSA-8963888 | 4.827838e-01 | 0.316 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 4.827838e-01 | 0.316 | 0 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 4.827838e-01 | 0.316 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 4.872651e-01 | 0.312 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 4.880127e-01 | 0.312 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 4.887831e-01 | 0.311 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 4.905047e-01 | 0.309 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 4.905047e-01 | 0.309 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 4.905047e-01 | 0.309 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 4.905047e-01 | 0.309 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 4.905047e-01 | 0.309 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 4.908534e-01 | 0.309 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 4.980950e-01 | 0.303 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 4.983744e-01 | 0.302 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 5.053147e-01 | 0.296 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 5.053147e-01 | 0.296 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 5.065870e-01 | 0.295 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 5.065870e-01 | 0.295 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 5.065870e-01 | 0.295 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 5.065870e-01 | 0.295 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 5.065870e-01 | 0.295 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 5.065870e-01 | 0.295 | 0 | 0 |
| Signaling by activated point mutants of FGFR1 | R-HSA-1839122 | 5.065870e-01 | 0.295 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 5.065870e-01 | 0.295 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 5.071284e-01 | 0.295 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 5.101075e-01 | 0.292 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 5.101075e-01 | 0.292 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 5.101075e-01 | 0.292 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 5.102642e-01 | 0.292 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 5.140582e-01 | 0.289 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 5.140582e-01 | 0.289 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 5.198422e-01 | 0.284 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 5.198422e-01 | 0.284 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 5.198422e-01 | 0.284 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 5.198422e-01 | 0.284 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 5.198422e-01 | 0.284 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 5.198422e-01 | 0.284 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 5.198422e-01 | 0.284 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 5.254471e-01 | 0.279 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 5.254471e-01 | 0.279 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 5.292961e-01 | 0.276 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 5.292961e-01 | 0.276 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 5.292961e-01 | 0.276 | 0 | 0 |
| Serotonin clearance from the synaptic cleft | R-HSA-380615 | 5.292961e-01 | 0.276 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 5.292961e-01 | 0.276 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 5.292961e-01 | 0.276 | 0 | 0 |
| Trafficking and processing of endosomal TLR | R-HSA-1679131 | 5.292961e-01 | 0.276 | 0 | 0 |
| Role of second messengers in netrin-1 signaling | R-HSA-418890 | 5.292961e-01 | 0.276 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD Domain Mutants | R-HSA-2691232 | 5.292961e-01 | 0.276 | 0 | 0 |
| Signaling by NOTCH1 HD Domain Mutants in Cancer | R-HSA-2691230 | 5.292961e-01 | 0.276 | 0 | 0 |
| Erythrocytes take up oxygen and release carbon dioxide | R-HSA-1247673 | 5.292961e-01 | 0.276 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 5.317124e-01 | 0.274 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 5.330094e-01 | 0.273 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 5.330094e-01 | 0.273 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 5.340816e-01 | 0.272 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 5.340816e-01 | 0.272 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 5.340816e-01 | 0.272 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 5.360759e-01 | 0.271 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 5.366872e-01 | 0.270 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 5.366872e-01 | 0.270 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 5.366872e-01 | 0.270 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 5.459767e-01 | 0.263 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 5.477741e-01 | 0.261 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 5.480287e-01 | 0.261 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 5.480287e-01 | 0.261 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 5.480287e-01 | 0.261 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 5.480287e-01 | 0.261 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 5.480939e-01 | 0.261 | 0 | 0 |
| Adenylate cyclase activating pathway | R-HSA-170660 | 5.509613e-01 | 0.259 | 0 | 0 |
| FGFR2c ligand binding and activation | R-HSA-190375 | 5.509613e-01 | 0.259 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 5.509613e-01 | 0.259 | 0 | 0 |
| FGFR4 ligand binding and activation | R-HSA-190322 | 5.509613e-01 | 0.259 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 5.509613e-01 | 0.259 | 0 | 0 |
| Diseases of nucleotide metabolism | R-HSA-9735804 | 5.509613e-01 | 0.259 | 0 | 0 |
| Signaling by activated point mutants of FGFR3 | R-HSA-1839130 | 5.509613e-01 | 0.259 | 0 | 0 |
| Mtb iron assimilation by chelation | R-HSA-1222449 | 5.509613e-01 | 0.259 | 0 | 0 |
| FGFR3 mutant receptor activation | R-HSA-2033514 | 5.509613e-01 | 0.259 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 5.509613e-01 | 0.259 | 0 | 0 |
| Acyl chain remodeling of DAG and TAG | R-HSA-1482883 | 5.509613e-01 | 0.259 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 5.509613e-01 | 0.259 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 5.509613e-01 | 0.259 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 5.579938e-01 | 0.253 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 5.616804e-01 | 0.251 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 5.616804e-01 | 0.251 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 5.624933e-01 | 0.250 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 5.665249e-01 | 0.247 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 5.665249e-01 | 0.247 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 5.665249e-01 | 0.247 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 5.694729e-01 | 0.245 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 5.694729e-01 | 0.245 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 5.716306e-01 | 0.243 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR3 | R-HSA-5654227 | 5.716306e-01 | 0.243 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 5.716306e-01 | 0.243 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 5.716306e-01 | 0.243 | 0 | 0 |
| FGFR3c ligand binding and activation | R-HSA-190372 | 5.716306e-01 | 0.243 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 5.716306e-01 | 0.243 | 0 | 0 |
| Physiological factors | R-HSA-5578768 | 5.716306e-01 | 0.243 | 0 | 0 |
| Non-canonical inflammasome activation | R-HSA-9686114 | 5.716306e-01 | 0.243 | 0 | 0 |
| HDL assembly | R-HSA-8963896 | 5.716306e-01 | 0.243 | 0 | 0 |
| Zinc transporters | R-HSA-435354 | 5.716306e-01 | 0.243 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 5.716306e-01 | 0.243 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 5.750341e-01 | 0.240 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 5.750341e-01 | 0.240 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 5.750341e-01 | 0.240 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 5.750341e-01 | 0.240 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 5.764291e-01 | 0.239 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 5.800782e-01 | 0.237 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 5.800782e-01 | 0.237 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 5.857060e-01 | 0.232 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 5.880885e-01 | 0.231 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 5.880885e-01 | 0.231 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 5.880885e-01 | 0.231 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 5.880885e-01 | 0.231 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 5.905171e-01 | 0.229 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 5.913497e-01 | 0.228 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 5.913497e-01 | 0.228 | 0 | 0 |
| Adenylate cyclase inhibitory pathway | R-HSA-170670 | 5.913497e-01 | 0.228 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR4 | R-HSA-5654228 | 5.913497e-01 | 0.228 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 5.913497e-01 | 0.228 | 0 | 0 |
| G beta:gamma signalling through BTK | R-HSA-8964315 | 5.913497e-01 | 0.228 | 0 | 0 |
| Telomere C-strand synthesis initiation | R-HSA-174430 | 5.913497e-01 | 0.228 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 5.913497e-01 | 0.228 | 0 | 0 |
| FGFR3 ligand binding and activation | R-HSA-190239 | 5.913497e-01 | 0.228 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 5.913497e-01 | 0.228 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 5.913497e-01 | 0.228 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 5.913497e-01 | 0.228 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 5.932912e-01 | 0.227 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 5.944206e-01 | 0.226 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 5.944206e-01 | 0.226 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 5.987677e-01 | 0.223 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 6.008428e-01 | 0.221 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 6.008428e-01 | 0.221 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 6.008428e-01 | 0.221 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 6.032443e-01 | 0.220 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 6.101622e-01 | 0.215 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 6.101622e-01 | 0.215 | 0 | 0 |
| Entry of Influenza Virion into Host Cell via Endocytosis | R-HSA-168275 | 6.101622e-01 | 0.215 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 6.101622e-01 | 0.215 | 0 | 0 |
| Class I peroxisomal membrane protein import | R-HSA-9603798 | 6.101622e-01 | 0.215 | 0 | 0 |
| TP53 Regulates Transcription of Caspase Activators and Caspases | R-HSA-6803207 | 6.101622e-01 | 0.215 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 6.101622e-01 | 0.215 | 0 | 0 |
| Induction of Cell-Cell Fusion | R-HSA-9733458 | 6.101622e-01 | 0.215 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 6.101622e-01 | 0.215 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 6.101622e-01 | 0.215 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 6.101622e-01 | 0.215 | 0 | 0 |
| Caspase activation via Death Receptors in the presence of ligand | R-HSA-140534 | 6.101622e-01 | 0.215 | 0 | 0 |
| Attachment and Entry | R-HSA-9678110 | 6.101622e-01 | 0.215 | 0 | 0 |
| Atorvastatin ADME | R-HSA-9754706 | 6.101622e-01 | 0.215 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 6.108863e-01 | 0.214 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 6.108863e-01 | 0.214 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 6.108863e-01 | 0.214 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 6.108863e-01 | 0.214 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 6.132969e-01 | 0.212 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 6.132969e-01 | 0.212 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 6.132969e-01 | 0.212 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 6.132969e-01 | 0.212 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 6.138653e-01 | 0.212 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 6.143732e-01 | 0.212 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 6.208130e-01 | 0.207 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 6.208130e-01 | 0.207 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 6.208130e-01 | 0.207 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 6.208130e-01 | 0.207 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 6.208130e-01 | 0.207 | 0 | 0 |
| Kinesins | R-HSA-983189 | 6.208130e-01 | 0.207 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 6.254515e-01 | 0.204 | 0 | 0 |
| Depurination | R-HSA-73927 | 6.254515e-01 | 0.204 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 6.254515e-01 | 0.204 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 6.254515e-01 | 0.204 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 6.281098e-01 | 0.202 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 6.281098e-01 | 0.202 | 0 | 0 |
| Antigen processing: Ub, ATP-independent proteasomal degradation | R-HSA-9912633 | 6.281098e-01 | 0.202 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 6.281098e-01 | 0.202 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 6.281098e-01 | 0.202 | 0 | 0 |
| TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling | R-HSA-975110 | 6.281098e-01 | 0.202 | 0 | 0 |
| Biosynthesis of maresin-like SPMs | R-HSA-9027307 | 6.281098e-01 | 0.202 | 0 | 0 |
| Heme assimilation | R-HSA-9927020 | 6.281098e-01 | 0.202 | 0 | 0 |
| Scavenging by Class B Receptors | R-HSA-3000471 | 6.281098e-01 | 0.202 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 6.281098e-01 | 0.202 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 6.281098e-01 | 0.202 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 6.281098e-01 | 0.202 | 0 | 0 |
| Galactose catabolism | R-HSA-70370 | 6.281098e-01 | 0.202 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 6.296181e-01 | 0.201 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 6.296181e-01 | 0.201 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 6.296181e-01 | 0.201 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 6.296279e-01 | 0.201 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 6.305659e-01 | 0.200 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 6.305659e-01 | 0.200 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 6.373077e-01 | 0.196 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 6.373077e-01 | 0.196 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 6.401437e-01 | 0.194 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 6.401437e-01 | 0.194 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 6.401437e-01 | 0.194 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 6.452321e-01 | 0.190 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 6.452321e-01 | 0.190 | 0 | 0 |
| Phospholipase C-mediated cascade: FGFR1 | R-HSA-5654219 | 6.452321e-01 | 0.190 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 6.452321e-01 | 0.190 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 6.452321e-01 | 0.190 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 6.452321e-01 | 0.190 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 6.452321e-01 | 0.190 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 6.452321e-01 | 0.190 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 6.488672e-01 | 0.188 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 6.488672e-01 | 0.188 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 6.488672e-01 | 0.188 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 6.488672e-01 | 0.188 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 6.488672e-01 | 0.188 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 6.495459e-01 | 0.187 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 6.495459e-01 | 0.187 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 6.517874e-01 | 0.186 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 6.585075e-01 | 0.181 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 6.601323e-01 | 0.180 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 6.601323e-01 | 0.180 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 6.601323e-01 | 0.180 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 6.601323e-01 | 0.180 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 6.615671e-01 | 0.179 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 6.615671e-01 | 0.179 | 0 | 0 |
| Activated point mutants of FGFR2 | R-HSA-2033519 | 6.615671e-01 | 0.179 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 6.615671e-01 | 0.179 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 6.615671e-01 | 0.179 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 6.615671e-01 | 0.179 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 6.615671e-01 | 0.179 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 6.615671e-01 | 0.179 | 0 | 0 |
| PKA activation | R-HSA-163615 | 6.615671e-01 | 0.179 | 0 | 0 |
| Vitamin D (calciferol) metabolism | R-HSA-196791 | 6.615671e-01 | 0.179 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 6.616458e-01 | 0.179 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 6.678212e-01 | 0.175 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 6.711054e-01 | 0.173 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 6.711054e-01 | 0.173 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 6.711054e-01 | 0.173 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 6.711054e-01 | 0.173 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 6.711054e-01 | 0.173 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 6.711054e-01 | 0.173 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 6.711054e-01 | 0.173 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 6.711054e-01 | 0.173 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 6.730958e-01 | 0.172 | 0 | 0 |
| Disease | R-HSA-1643685 | 6.745637e-01 | 0.171 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 6.771509e-01 | 0.169 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 6.771509e-01 | 0.169 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 6.771509e-01 | 0.169 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 6.771509e-01 | 0.169 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 6.771509e-01 | 0.169 | 0 | 0 |
| Pyrimidine biosynthesis | R-HSA-500753 | 6.771509e-01 | 0.169 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 6.771509e-01 | 0.169 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 6.771509e-01 | 0.169 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 6.771509e-01 | 0.169 | 0 | 0 |
| Erythrocytes take up carbon dioxide and release oxygen | R-HSA-1237044 | 6.771509e-01 | 0.169 | 0 | 0 |
| O2/CO2 exchange in erythrocytes | R-HSA-1480926 | 6.771509e-01 | 0.169 | 0 | 0 |
| Pre-NOTCH Processing in Golgi | R-HSA-1912420 | 6.771509e-01 | 0.169 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 6.771509e-01 | 0.169 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 6.791237e-01 | 0.168 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 6.817897e-01 | 0.166 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 6.817897e-01 | 0.166 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 6.817897e-01 | 0.166 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 6.853907e-01 | 0.164 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 6.853907e-01 | 0.164 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR2 | R-HSA-5654221 | 6.920180e-01 | 0.160 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 6.920180e-01 | 0.160 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 6.920180e-01 | 0.160 | 0 | 0 |
| Common Pathway of Fibrin Clot Formation | R-HSA-140875 | 6.920180e-01 | 0.160 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 6.920180e-01 | 0.160 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 6.921884e-01 | 0.160 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 6.921884e-01 | 0.160 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 6.935247e-01 | 0.159 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 6.939113e-01 | 0.159 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 6.939113e-01 | 0.159 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 7.023051e-01 | 0.153 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 7.051940e-01 | 0.152 | 0 | 0 |
| FGFR2 ligand binding and activation | R-HSA-190241 | 7.062013e-01 | 0.151 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 7.062013e-01 | 0.151 | 0 | 0 |
| Intrinsic Pathway of Fibrin Clot Formation | R-HSA-140837 | 7.062013e-01 | 0.151 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 7.062013e-01 | 0.151 | 0 | 0 |
| Synthesis, secretion, and deacylation of Ghrelin | R-HSA-422085 | 7.062013e-01 | 0.151 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 7.062013e-01 | 0.151 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 7.062013e-01 | 0.151 | 0 | 0 |
| Prevention of phagosomal-lysosomal fusion | R-HSA-9636383 | 7.062013e-01 | 0.151 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 7.062013e-01 | 0.151 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 7.068412e-01 | 0.151 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 7.104273e-01 | 0.148 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 7.121439e-01 | 0.147 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 7.121439e-01 | 0.147 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 7.121439e-01 | 0.147 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 7.121439e-01 | 0.147 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 7.121439e-01 | 0.147 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 7.161798e-01 | 0.145 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 7.161798e-01 | 0.145 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 7.197323e-01 | 0.143 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 7.197323e-01 | 0.143 | 0 | 0 |
| Glutathione synthesis and recycling | R-HSA-174403 | 7.197323e-01 | 0.143 | 0 | 0 |
| Attachment and Entry | R-HSA-9694614 | 7.197323e-01 | 0.143 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 7.197323e-01 | 0.143 | 0 | 0 |
| Ribavirin ADME | R-HSA-9755088 | 7.197323e-01 | 0.143 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 7.197323e-01 | 0.143 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 7.215681e-01 | 0.142 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 7.217087e-01 | 0.142 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 7.217087e-01 | 0.142 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 7.217087e-01 | 0.142 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 7.217087e-01 | 0.142 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 7.217087e-01 | 0.142 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 7.246330e-01 | 0.140 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 7.256093e-01 | 0.139 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 7.310040e-01 | 0.136 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 7.321350e-01 | 0.135 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 7.326409e-01 | 0.135 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 7.326409e-01 | 0.135 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 7.326409e-01 | 0.135 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 7.326409e-01 | 0.135 | 0 | 0 |
| Cholesterol biosynthesis via lathosterol | R-HSA-6807062 | 7.326409e-01 | 0.135 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 7.344412e-01 | 0.134 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 7.399560e-01 | 0.131 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 7.400343e-01 | 0.131 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 7.400343e-01 | 0.131 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 7.400343e-01 | 0.131 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 7.400343e-01 | 0.131 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 7.413867e-01 | 0.130 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 7.413867e-01 | 0.130 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 7.413867e-01 | 0.130 | 0 | 0 |
| Biosynthesis of maresins | R-HSA-9018682 | 7.449557e-01 | 0.128 | 0 | 0 |
| Synthesis of pyrophosphates in the cytosol | R-HSA-1855167 | 7.449557e-01 | 0.128 | 0 | 0 |
| Free fatty acids regulate insulin secretion | R-HSA-400451 | 7.449557e-01 | 0.128 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 7.449557e-01 | 0.128 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 7.474883e-01 | 0.126 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 7.487023e-01 | 0.126 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 7.487023e-01 | 0.126 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 7.488042e-01 | 0.126 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 7.488042e-01 | 0.126 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 7.488042e-01 | 0.126 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 7.563617e-01 | 0.121 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 7.563617e-01 | 0.121 | 0 | 0 |
| CYP2E1 reactions | R-HSA-211999 | 7.567040e-01 | 0.121 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 7.567040e-01 | 0.121 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 7.567040e-01 | 0.121 | 0 | 0 |
| TNFs bind their physiological receptors | R-HSA-5669034 | 7.567040e-01 | 0.121 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 7.573186e-01 | 0.121 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 7.607960e-01 | 0.119 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 7.633599e-01 | 0.117 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 7.633599e-01 | 0.117 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 7.655824e-01 | 0.116 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 7.655824e-01 | 0.116 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 7.655824e-01 | 0.116 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 7.679118e-01 | 0.115 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 7.679118e-01 | 0.115 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 7.679118e-01 | 0.115 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 7.679118e-01 | 0.115 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 7.679118e-01 | 0.115 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 7.679118e-01 | 0.115 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 7.679118e-01 | 0.115 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 7.696569e-01 | 0.114 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 7.696569e-01 | 0.114 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 7.734113e-01 | 0.112 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 7.736007e-01 | 0.111 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 7.763172e-01 | 0.110 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 7.772923e-01 | 0.109 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 7.786039e-01 | 0.109 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 7.786039e-01 | 0.109 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 7.786039e-01 | 0.109 | 0 | 0 |
| Synthesis of IP2, IP, and Ins in the cytosol | R-HSA-1855183 | 7.786039e-01 | 0.109 | 0 | 0 |
| Abacavir ADME | R-HSA-2161522 | 7.786039e-01 | 0.109 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 7.786039e-01 | 0.109 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 7.786039e-01 | 0.109 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 7.805580e-01 | 0.108 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 7.813784e-01 | 0.107 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 7.813784e-01 | 0.107 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 7.875685e-01 | 0.104 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 7.888041e-01 | 0.103 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 7.888041e-01 | 0.103 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 7.888041e-01 | 0.103 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 7.888041e-01 | 0.103 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 7.888041e-01 | 0.103 | 0 | 0 |
| Signaling by BMP | R-HSA-201451 | 7.888041e-01 | 0.103 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 7.888041e-01 | 0.103 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 7.888041e-01 | 0.103 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 7.888041e-01 | 0.103 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 7.889207e-01 | 0.103 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 7.896213e-01 | 0.103 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 7.962328e-01 | 0.099 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 7.971355e-01 | 0.098 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 7.985349e-01 | 0.098 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 7.985349e-01 | 0.098 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 7.985349e-01 | 0.098 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 7.985349e-01 | 0.098 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 7.985349e-01 | 0.098 | 0 | 0 |
| Prednisone ADME | R-HSA-9757110 | 7.985349e-01 | 0.098 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 8.013909e-01 | 0.096 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 8.072784e-01 | 0.093 | 0 | 0 |
| Thyroxine biosynthesis | R-HSA-209968 | 8.078179e-01 | 0.093 | 0 | 0 |
| Activation of Matrix Metalloproteinases | R-HSA-1592389 | 8.078179e-01 | 0.093 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 8.101871e-01 | 0.091 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 8.147010e-01 | 0.089 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 8.166738e-01 | 0.088 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 8.166738e-01 | 0.088 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 8.166738e-01 | 0.088 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 8.166738e-01 | 0.088 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 8.166738e-01 | 0.088 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 8.168398e-01 | 0.088 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 8.186126e-01 | 0.087 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 8.232830e-01 | 0.084 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 8.232830e-01 | 0.084 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 8.232830e-01 | 0.084 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 8.251221e-01 | 0.083 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 8.251221e-01 | 0.083 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 8.251221e-01 | 0.083 | 0 | 0 |
| Synthesis of glycosylphosphatidylinositol (GPI) | R-HSA-162710 | 8.251221e-01 | 0.083 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 8.252863e-01 | 0.083 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 8.254534e-01 | 0.083 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 8.295219e-01 | 0.081 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 8.301743e-01 | 0.081 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 8.331815e-01 | 0.079 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 8.331815e-01 | 0.079 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 8.346992e-01 | 0.078 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 8.346992e-01 | 0.078 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 8.346992e-01 | 0.078 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 8.355616e-01 | 0.078 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 8.355616e-01 | 0.078 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 8.355616e-01 | 0.078 | 0 | 0 |
| Defective B3GALTL causes PpS | R-HSA-5083635 | 8.408700e-01 | 0.075 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 8.408700e-01 | 0.075 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 8.408700e-01 | 0.075 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 8.408700e-01 | 0.075 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 8.408700e-01 | 0.075 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 8.408700e-01 | 0.075 | 0 | 0 |
| Diseases associated with glycosylation precursor biosynthesis | R-HSA-5609975 | 8.408700e-01 | 0.075 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 8.414074e-01 | 0.075 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 8.414074e-01 | 0.075 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 8.482046e-01 | 0.071 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 8.482046e-01 | 0.071 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 8.482046e-01 | 0.071 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 8.482046e-01 | 0.071 | 0 | 0 |
| Heme degradation | R-HSA-189483 | 8.482046e-01 | 0.071 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 8.498177e-01 | 0.071 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 8.534993e-01 | 0.069 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 8.539094e-01 | 0.069 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 8.545503e-01 | 0.068 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 8.552015e-01 | 0.068 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 8.552015e-01 | 0.068 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 8.552015e-01 | 0.068 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 8.552015e-01 | 0.068 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 8.552015e-01 | 0.068 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 8.552015e-01 | 0.068 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 8.552015e-01 | 0.068 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 8.552015e-01 | 0.068 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 8.552015e-01 | 0.068 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 8.561922e-01 | 0.067 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 8.584298e-01 | 0.066 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 8.618763e-01 | 0.065 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 8.629499e-01 | 0.064 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 8.629499e-01 | 0.064 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 8.640997e-01 | 0.063 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 8.671042e-01 | 0.062 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 8.678999e-01 | 0.062 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 8.682438e-01 | 0.061 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 8.682438e-01 | 0.061 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 8.682438e-01 | 0.061 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 8.682438e-01 | 0.061 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 8.682438e-01 | 0.061 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 8.682438e-01 | 0.061 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 8.682438e-01 | 0.061 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 8.736326e-01 | 0.059 | 0 | 0 |
| O-glycosylation of TSR domain-containing proteins | R-HSA-5173214 | 8.743182e-01 | 0.058 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 8.743182e-01 | 0.058 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 8.743182e-01 | 0.058 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 8.743182e-01 | 0.058 | 0 | 0 |
| SLC-mediated transport of organic cations | R-HSA-549127 | 8.743182e-01 | 0.058 | 0 | 0 |
| Beta-oxidation of very long chain fatty acids | R-HSA-390247 | 8.743182e-01 | 0.058 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 8.753070e-01 | 0.058 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 8.788018e-01 | 0.056 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 8.793427e-01 | 0.056 | 0 | 0 |
| Purine salvage | R-HSA-74217 | 8.801128e-01 | 0.055 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 8.801128e-01 | 0.055 | 0 | 0 |
| alpha-linolenic acid (ALA) metabolism | R-HSA-2046106 | 8.801128e-01 | 0.055 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 8.856406e-01 | 0.053 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 8.856406e-01 | 0.053 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 8.856406e-01 | 0.053 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 8.856406e-01 | 0.053 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 8.856406e-01 | 0.053 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 8.856406e-01 | 0.053 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 8.860994e-01 | 0.053 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 8.860994e-01 | 0.053 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 8.867701e-01 | 0.052 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 8.880284e-01 | 0.052 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 8.909139e-01 | 0.050 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 8.909139e-01 | 0.050 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 8.909139e-01 | 0.050 | 0 | 0 |
| Maturation of TCA enzymes and regulation of TCA cycle | R-HSA-9854311 | 8.909139e-01 | 0.050 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 8.909139e-01 | 0.050 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 8.909139e-01 | 0.050 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 8.909139e-01 | 0.050 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 8.943020e-01 | 0.049 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 8.943020e-01 | 0.049 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 8.949056e-01 | 0.048 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 8.959443e-01 | 0.048 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 8.959443e-01 | 0.048 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 8.981942e-01 | 0.047 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 9.005871e-01 | 0.045 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 9.007430e-01 | 0.045 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 9.007430e-01 | 0.045 | 0 | 0 |
| Scavenging by Class A Receptors | R-HSA-3000480 | 9.007430e-01 | 0.045 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 9.007430e-01 | 0.045 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 9.017061e-01 | 0.045 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 9.038164e-01 | 0.044 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 9.043591e-01 | 0.044 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 9.053207e-01 | 0.043 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 9.053207e-01 | 0.043 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 9.053207e-01 | 0.043 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 9.053207e-01 | 0.043 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 9.055811e-01 | 0.043 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.068224e-01 | 0.042 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 9.099323e-01 | 0.041 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 9.124646e-01 | 0.040 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 9.124646e-01 | 0.040 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 9.124646e-01 | 0.040 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 9.138533e-01 | 0.039 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 9.138533e-01 | 0.039 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 9.143568e-01 | 0.039 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 9.157273e-01 | 0.038 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.174491e-01 | 0.037 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 9.178271e-01 | 0.037 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 9.178271e-01 | 0.037 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 9.178271e-01 | 0.037 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 9.216178e-01 | 0.035 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 9.216178e-01 | 0.035 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 9.249203e-01 | 0.034 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 9.252338e-01 | 0.034 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 9.252338e-01 | 0.034 | 0 | 0 |
| alpha-linolenic (omega3) and linoleic (omega6) acid metabolism | R-HSA-2046104 | 9.252338e-01 | 0.034 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 9.276691e-01 | 0.033 | 0 | 0 |
| Plasma lipoprotein remodeling | R-HSA-8963899 | 9.286833e-01 | 0.032 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 9.291029e-01 | 0.032 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 9.295551e-01 | 0.032 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 9.319738e-01 | 0.031 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 9.333335e-01 | 0.030 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 9.351127e-01 | 0.029 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 9.354327e-01 | 0.029 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.380004e-01 | 0.028 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 9.398486e-01 | 0.027 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 9.403556e-01 | 0.027 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 9.409631e-01 | 0.026 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 9.409631e-01 | 0.026 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 9.409631e-01 | 0.026 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.418732e-01 | 0.026 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 9.426256e-01 | 0.026 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 9.436877e-01 | 0.025 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 9.436877e-01 | 0.025 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 9.462867e-01 | 0.024 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 9.469215e-01 | 0.024 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.469215e-01 | 0.024 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 9.469215e-01 | 0.024 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 9.487659e-01 | 0.023 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 9.489528e-01 | 0.023 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.498440e-01 | 0.022 | 0 | 0 |
| Metabolism of amine-derived hormones | R-HSA-209776 | 9.511308e-01 | 0.022 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 9.511308e-01 | 0.022 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 9.511308e-01 | 0.022 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 9.517924e-01 | 0.021 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 9.527953e-01 | 0.021 | 0 | 0 |
| Protein folding | R-HSA-391251 | 9.527953e-01 | 0.021 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 9.533867e-01 | 0.021 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 9.555386e-01 | 0.020 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 9.563605e-01 | 0.019 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 9.580450e-01 | 0.019 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 9.595493e-01 | 0.018 | 0 | 0 |
| Glutathione conjugation | R-HSA-156590 | 9.595493e-01 | 0.018 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 9.595493e-01 | 0.018 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 9.596672e-01 | 0.018 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.612291e-01 | 0.017 | 0 | 0 |
| Nucleotide salvage | R-HSA-8956321 | 9.614170e-01 | 0.017 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 9.614170e-01 | 0.017 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 9.622688e-01 | 0.017 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 9.631987e-01 | 0.016 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 9.631987e-01 | 0.016 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.642165e-01 | 0.016 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 9.648981e-01 | 0.016 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 9.648981e-01 | 0.016 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.652935e-01 | 0.015 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.655744e-01 | 0.015 | 0 | 0 |
| Xenobiotics | R-HSA-211981 | 9.665192e-01 | 0.015 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.677906e-01 | 0.014 | 0 | 0 |
| Latent infection - Other responses of Mtb to phagocytosis | R-HSA-1222499 | 9.680654e-01 | 0.014 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 9.682069e-01 | 0.014 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 9.694494e-01 | 0.013 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 9.706451e-01 | 0.013 | 0 | 0 |
| Nicotinate metabolism | R-HSA-196807 | 9.709473e-01 | 0.013 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 9.718841e-01 | 0.012 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.722894e-01 | 0.012 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 9.729873e-01 | 0.012 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 9.738356e-01 | 0.012 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 9.758722e-01 | 0.011 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.759552e-01 | 0.011 | 0 | 0 |
| Metal ion assimilation from the host | R-HSA-9638482 | 9.759552e-01 | 0.011 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.759552e-01 | 0.011 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 9.759552e-01 | 0.011 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 9.759774e-01 | 0.011 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 9.759774e-01 | 0.011 | 0 | 0 |
| Purine catabolism | R-HSA-74259 | 9.770662e-01 | 0.010 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 9.777224e-01 | 0.010 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 9.781259e-01 | 0.010 | 0 | 0 |
| Aspirin ADME | R-HSA-9749641 | 9.781259e-01 | 0.010 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.784568e-01 | 0.009 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.787137e-01 | 0.009 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.788347e-01 | 0.009 | 0 | 0 |
| Translation | R-HSA-72766 | 9.788631e-01 | 0.009 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 9.791367e-01 | 0.009 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.798577e-01 | 0.009 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.798577e-01 | 0.009 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 9.801008e-01 | 0.009 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.809905e-01 | 0.008 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 9.818977e-01 | 0.008 | 0 | 0 |
| Metabolic disorders of biological oxidation enzymes | R-HSA-5579029 | 9.835325e-01 | 0.007 | 0 | 0 |
| Biosynthesis of DHA-derived SPMs | R-HSA-9018677 | 9.850198e-01 | 0.007 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 9.855775e-01 | 0.006 | 0 | 0 |
| Peroxisomal lipid metabolism | R-HSA-390918 | 9.870030e-01 | 0.006 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 9.870338e-01 | 0.006 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 9.873094e-01 | 0.006 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 9.887240e-01 | 0.005 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 9.887399e-01 | 0.005 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 9.892455e-01 | 0.005 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 9.897429e-01 | 0.004 | 0 | 0 |
| Class C/3 (Metabotropic glutamate/pheromone receptors) | R-HSA-420499 | 9.897429e-01 | 0.004 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.902033e-01 | 0.004 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.906699e-01 | 0.004 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 9.922803e-01 | 0.003 | 0 | 0 |
| Scavenging of heme from plasma | R-HSA-2168880 | 9.933032e-01 | 0.003 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 9.935743e-01 | 0.003 | 0 | 0 |
| Mitochondrial translation elongation | R-HSA-5389840 | 9.936131e-01 | 0.003 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 9.939087e-01 | 0.003 | 0 | 0 |
| Mitochondrial translation initiation | R-HSA-5368286 | 9.941907e-01 | 0.003 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 9.954165e-01 | 0.002 | 0 | 0 |
| Post-translational modification: synthesis of GPI-anchored proteins | R-HSA-163125 | 9.958311e-01 | 0.002 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 9.963898e-01 | 0.002 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.964000e-01 | 0.002 | 0 | 0 |
| Mitochondrial translation termination | R-HSA-5419276 | 9.967111e-01 | 0.001 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.967181e-01 | 0.001 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.970088e-01 | 0.001 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.976792e-01 | 0.001 | 0 | 0 |
| Regulation of Complement cascade | R-HSA-977606 | 9.986002e-01 | 0.001 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 9.988960e-01 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 9.989174e-01 | 0.000 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.989174e-01 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 9.992885e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 9.993135e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 9.993454e-01 | 0.000 | 0 | 0 |
| Biosynthesis of specialized proresolving mediators (SPMs) | R-HSA-9018678 | 9.995079e-01 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.995327e-01 | 0.000 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.995513e-01 | 0.000 | 0 | 0 |
| Complement cascade | R-HSA-166658 | 9.995525e-01 | 0.000 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.996183e-01 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 9.996977e-01 | 0.000 | 0 | 0 |
| Cytochrome P450 - arranged by substrate type | R-HSA-211897 | 9.998429e-01 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 9.999566e-01 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 9.999642e-01 | 0.000 | 0 | 0 |
| Infection with Enterobacteria | R-HSA-9640148 | 9.999731e-01 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 9.999892e-01 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 9.999926e-01 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.999929e-01 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 9.999943e-01 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 9.999954e-01 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 9.999998e-01 | 0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | 0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
Top15 pathways (red highlights are reference pathways)
Compared with reference pathways
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Cellular response to heat stress | R-HSA-3371556 | 9.315138e-11 | 10.031 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 3.999572e-09 | 8.398 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 6.164569e-09 | 8.210 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 7.310399e-09 | 8.136 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 9.141530e-09 | 8.039 | 0 | 0 |
| M Phase | R-HSA-68886 | 1.174852e-08 | 7.930 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 1.307543e-08 | 7.884 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 1.698702e-08 | 7.770 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 2.124872e-07 | 6.673 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 2.766931e-07 | 6.558 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 4.320564e-07 | 6.364 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 2.024215e-06 | 5.694 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 2.024215e-06 | 5.694 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 2.024215e-06 | 5.694 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 2.024215e-06 | 5.694 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 2.001784e-06 | 5.699 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 2.329222e-06 | 5.633 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 2.810428e-06 | 5.551 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 2.756230e-06 | 5.560 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 3.563809e-06 | 5.448 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 4.184943e-06 | 5.378 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 5.203463e-06 | 5.284 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 5.570913e-06 | 5.254 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 6.615578e-06 | 5.179 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 6.228029e-06 | 5.206 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 6.529856e-06 | 5.185 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 7.547172e-06 | 5.122 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 7.939545e-06 | 5.100 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 8.630997e-06 | 5.064 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 9.862425e-06 | 5.006 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 9.367537e-06 | 5.028 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 9.876758e-06 | 5.005 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 1.053207e-05 | 4.977 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 1.076277e-05 | 4.968 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 1.093039e-05 | 4.961 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 1.296777e-05 | 4.887 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 1.459207e-05 | 4.836 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 1.429967e-05 | 4.845 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 1.577023e-05 | 4.802 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 2.193822e-05 | 4.659 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 2.298269e-05 | 4.639 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 2.696658e-05 | 4.569 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 4.837885e-05 | 4.315 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 4.867217e-05 | 4.313 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 5.312010e-05 | 4.275 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 5.596795e-05 | 4.252 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 6.879819e-05 | 4.162 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 6.879819e-05 | 4.162 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 7.268009e-05 | 4.139 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 8.285368e-05 | 4.082 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 8.285368e-05 | 4.082 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 8.285368e-05 | 4.082 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 8.535970e-05 | 4.069 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 8.646389e-05 | 4.063 | 0 | 0 |
| Kinesins | R-HSA-983189 | 9.779264e-05 | 4.010 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 1.019664e-04 | 3.992 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 1.134858e-04 | 3.945 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 1.230227e-04 | 3.910 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 1.380890e-04 | 3.860 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 1.471365e-04 | 3.832 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 1.587939e-04 | 3.799 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 1.567076e-04 | 3.805 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 1.761382e-04 | 3.754 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 1.860022e-04 | 3.730 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 1.860022e-04 | 3.730 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 1.921826e-04 | 3.716 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 1.921826e-04 | 3.716 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 2.034506e-04 | 3.692 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 2.091323e-04 | 3.680 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 2.334517e-04 | 3.632 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 2.502271e-04 | 3.602 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 2.845650e-04 | 3.546 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 2.865961e-04 | 3.543 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 2.906256e-04 | 3.537 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 3.403008e-04 | 3.468 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 3.408981e-04 | 3.467 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 3.474465e-04 | 3.459 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 3.758363e-04 | 3.425 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 3.805148e-04 | 3.420 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 3.806887e-04 | 3.419 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 4.607683e-04 | 3.337 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 4.941747e-04 | 3.306 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 5.544053e-04 | 3.256 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 5.544053e-04 | 3.256 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 5.576562e-04 | 3.254 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 6.217397e-04 | 3.206 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 6.946530e-04 | 3.158 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 6.976355e-04 | 3.156 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 6.976355e-04 | 3.156 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 7.573851e-04 | 3.121 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 7.573851e-04 | 3.121 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 9.207137e-04 | 3.036 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 9.352480e-04 | 3.029 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 9.531650e-04 | 3.021 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 9.887116e-04 | 3.005 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 1.167719e-03 | 2.933 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 1.181888e-03 | 2.927 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 1.281819e-03 | 2.892 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 1.281819e-03 | 2.892 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 1.247925e-03 | 2.904 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 1.247925e-03 | 2.904 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 1.432022e-03 | 2.844 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 1.473141e-03 | 2.832 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 1.508360e-03 | 2.821 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 1.572887e-03 | 2.803 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 1.572887e-03 | 2.803 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 1.572887e-03 | 2.803 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 1.659551e-03 | 2.780 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 1.554785e-03 | 2.808 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 1.698690e-03 | 2.770 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 1.802154e-03 | 2.744 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 1.832896e-03 | 2.737 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 2.080598e-03 | 2.682 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 2.125053e-03 | 2.673 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 2.215417e-03 | 2.655 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 2.462459e-03 | 2.609 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 2.451936e-03 | 2.610 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 2.462459e-03 | 2.609 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 2.442836e-03 | 2.612 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 2.472262e-03 | 2.607 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 2.534100e-03 | 2.596 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 2.916868e-03 | 2.535 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 3.106468e-03 | 2.508 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 3.152468e-03 | 2.501 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 3.201367e-03 | 2.495 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 3.220540e-03 | 2.492 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 3.270892e-03 | 2.485 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 3.461640e-03 | 2.461 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 3.587719e-03 | 2.445 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 4.032569e-03 | 2.394 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 4.053081e-03 | 2.392 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 4.053081e-03 | 2.392 | 0 | 0 |
| Nectin/Necl trans heterodimerization | R-HSA-420597 | 4.337208e-03 | 2.363 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 4.546082e-03 | 2.342 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 4.611258e-03 | 2.336 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 4.782342e-03 | 2.320 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 4.782342e-03 | 2.320 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 4.611258e-03 | 2.336 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 4.883035e-03 | 2.311 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 5.242561e-03 | 2.280 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 5.310776e-03 | 2.275 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 5.516728e-03 | 2.258 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 5.539948e-03 | 2.256 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 6.084967e-03 | 2.216 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 6.084967e-03 | 2.216 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 6.259735e-03 | 2.203 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 6.746445e-03 | 2.171 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 6.746445e-03 | 2.171 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 6.938209e-03 | 2.159 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 7.280418e-03 | 2.138 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 7.411616e-03 | 2.130 | 0 | 0 |
| Manipulation of host energy metabolism | R-HSA-9636667 | 8.641166e-03 | 2.063 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 7.921974e-03 | 2.101 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 8.557882e-03 | 2.068 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 8.641166e-03 | 2.063 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 8.044500e-03 | 2.095 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 7.642038e-03 | 2.117 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 8.935969e-03 | 2.049 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 9.331492e-03 | 2.030 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 9.570625e-03 | 2.019 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 1.006512e-02 | 1.997 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 1.010925e-02 | 1.995 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 1.026668e-02 | 1.989 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 1.044410e-02 | 1.981 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 1.070838e-02 | 1.970 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 1.079610e-02 | 1.967 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 1.088680e-02 | 1.963 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 1.108671e-02 | 1.955 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 1.110888e-02 | 1.954 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 1.126798e-02 | 1.948 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 1.143226e-02 | 1.942 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 1.143226e-02 | 1.942 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 1.206010e-02 | 1.919 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 1.471591e-02 | 1.832 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 1.287272e-02 | 1.890 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 1.395680e-02 | 1.855 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 1.269580e-02 | 1.896 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 1.271021e-02 | 1.896 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 1.438723e-02 | 1.842 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 1.452076e-02 | 1.838 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 1.490649e-02 | 1.827 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 1.490649e-02 | 1.827 | 0 | 0 |
| Signalling to ERK5 | R-HSA-198765 | 1.490649e-02 | 1.827 | 1 | 1 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 1.490649e-02 | 1.827 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 1.490649e-02 | 1.827 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 1.490649e-02 | 1.827 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 1.490649e-02 | 1.827 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 1.490649e-02 | 1.827 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 1.490649e-02 | 1.827 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 1.490649e-02 | 1.827 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 1.490649e-02 | 1.827 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 1.490649e-02 | 1.827 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 1.506436e-02 | 1.822 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 1.569964e-02 | 1.804 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 1.570448e-02 | 1.804 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 1.578167e-02 | 1.802 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 1.594086e-02 | 1.797 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 1.604881e-02 | 1.795 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 1.676911e-02 | 1.775 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 1.702323e-02 | 1.769 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 1.706655e-02 | 1.768 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 1.826256e-02 | 1.738 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 1.847847e-02 | 1.733 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 1.848494e-02 | 1.733 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 1.889185e-02 | 1.724 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 1.889185e-02 | 1.724 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 2.272490e-02 | 1.643 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 2.129077e-02 | 1.672 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in metabolism | R-HSA-9854907 | 2.260331e-02 | 1.646 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 1.949903e-02 | 1.710 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 2.248800e-02 | 1.648 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 2.248800e-02 | 1.648 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 2.272911e-02 | 1.643 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 2.371271e-02 | 1.625 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 2.388212e-02 | 1.622 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 2.388212e-02 | 1.622 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 2.414027e-02 | 1.617 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 2.497271e-02 | 1.603 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 2.574126e-02 | 1.589 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 3.159095e-02 | 1.500 | 0 | 0 |
| Signaling by MAP2K mutants | R-HSA-9652169 | 3.159095e-02 | 1.500 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 2.745633e-02 | 1.561 | 0 | 0 |
| ERKs are inactivated | R-HSA-202670 | 3.267049e-02 | 1.486 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 2.926297e-02 | 1.534 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 3.305626e-02 | 1.481 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 2.926297e-02 | 1.534 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 3.159095e-02 | 1.500 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 3.267049e-02 | 1.486 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 2.833836e-02 | 1.548 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 2.946185e-02 | 1.531 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 3.305626e-02 | 1.481 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 3.305626e-02 | 1.481 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 3.152415e-02 | 1.501 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 2.824364e-02 | 1.549 | 1 | 0 |
| Hemostasis | R-HSA-109582 | 2.941930e-02 | 1.531 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 3.305626e-02 | 1.481 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 3.074631e-02 | 1.512 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 3.354868e-02 | 1.474 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 3.429512e-02 | 1.465 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 3.466916e-02 | 1.460 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 3.484132e-02 | 1.458 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 3.514932e-02 | 1.454 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 3.548186e-02 | 1.450 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 3.548186e-02 | 1.450 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 3.548186e-02 | 1.450 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 3.558377e-02 | 1.449 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 3.565979e-02 | 1.448 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 3.568010e-02 | 1.448 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 3.641259e-02 | 1.439 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 3.708930e-02 | 1.431 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 3.836212e-02 | 1.416 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 3.883993e-02 | 1.411 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 4.014696e-02 | 1.396 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 4.173844e-02 | 1.379 | 0 | 0 |
| Post-transcriptional silencing by small RNAs | R-HSA-426496 | 4.173844e-02 | 1.379 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 4.173844e-02 | 1.379 | 0 | 0 |
| Resolution of AP sites via the single-nucleotide replacement pathway | R-HSA-110381 | 4.173844e-02 | 1.379 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 4.178828e-02 | 1.379 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 4.224331e-02 | 1.374 | 1 | 0 |
| RAF activation | R-HSA-5673000 | 4.238541e-02 | 1.373 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 4.335828e-02 | 1.363 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 4.452335e-02 | 1.351 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 4.452335e-02 | 1.351 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 4.500688e-02 | 1.347 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 4.500688e-02 | 1.347 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 4.557164e-02 | 1.341 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 4.608199e-02 | 1.336 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 4.611961e-02 | 1.336 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 4.630689e-02 | 1.334 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 4.655579e-02 | 1.332 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 4.786932e-02 | 1.320 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 4.786932e-02 | 1.320 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 4.786932e-02 | 1.320 | 0 | 0 |
| Protein folding | R-HSA-391251 | 4.868353e-02 | 1.313 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 4.868353e-02 | 1.313 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 5.346416e-02 | 1.272 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 6.503416e-02 | 1.187 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 6.571342e-02 | 1.182 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 6.571342e-02 | 1.182 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 6.571342e-02 | 1.182 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 6.727360e-02 | 1.172 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 6.763915e-02 | 1.170 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 6.875670e-02 | 1.163 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 5.714022e-02 | 1.243 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 7.146961e-02 | 1.146 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 7.146961e-02 | 1.146 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 6.352500e-02 | 1.197 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 6.352500e-02 | 1.197 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 5.874663e-02 | 1.231 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 5.994818e-02 | 1.222 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 5.613728e-02 | 1.251 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 5.395262e-02 | 1.268 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 6.264855e-02 | 1.203 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 6.765243e-02 | 1.170 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 6.814359e-02 | 1.167 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 6.690558e-02 | 1.175 | 0 | 0 |
| Signaling by LTK in cancer | R-HSA-9842640 | 6.503416e-02 | 1.187 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 6.959695e-02 | 1.157 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 5.748724e-02 | 1.240 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 6.938495e-02 | 1.159 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 7.251069e-02 | 1.140 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 7.323891e-02 | 1.135 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 7.323891e-02 | 1.135 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 7.350394e-02 | 1.134 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 7.489284e-02 | 1.126 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 7.756896e-02 | 1.110 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 7.796389e-02 | 1.108 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 7.880700e-02 | 1.103 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 7.946320e-02 | 1.100 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 7.946320e-02 | 1.100 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 8.195462e-02 | 1.086 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 8.195462e-02 | 1.086 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 8.203107e-02 | 1.086 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 8.205251e-02 | 1.086 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 8.209629e-02 | 1.086 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 8.281220e-02 | 1.082 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 8.594135e-02 | 1.066 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 8.709932e-02 | 1.060 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 8.770314e-02 | 1.057 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 8.770314e-02 | 1.057 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 8.770314e-02 | 1.057 | 0 | 0 |
| Hereditary fructose intolerance | R-HSA-5657560 | 8.770314e-02 | 1.057 | 0 | 0 |
| RPIA deficiency: failed conversion of RU5P to R5P | R-HSA-6791461 | 8.770314e-02 | 1.057 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 8.770314e-02 | 1.057 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 8.770314e-02 | 1.057 | 0 | 0 |
| RPIA deficiency: failed conversion of R5P to RU5P | R-HSA-5659996 | 8.770314e-02 | 1.057 | 0 | 0 |
| Formation of editosomes by ADAR proteins | R-HSA-77042 | 8.770314e-02 | 1.057 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 8.823827e-02 | 1.054 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 8.928932e-02 | 1.049 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 8.960521e-02 | 1.048 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 9.066051e-02 | 1.043 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 9.121814e-02 | 1.040 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 9.161547e-02 | 1.038 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 9.161547e-02 | 1.038 | 0 | 0 |
| Regulation of NPAS4 mRNA translation | R-HSA-9768778 | 9.161547e-02 | 1.038 | 0 | 0 |
| BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members | R-HSA-111453 | 9.161547e-02 | 1.038 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 9.161547e-02 | 1.038 | 0 | 0 |
| RSK activation | R-HSA-444257 | 9.161547e-02 | 1.038 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 9.161547e-02 | 1.038 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 9.384474e-02 | 1.028 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 9.671601e-02 | 1.015 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 9.747078e-02 | 1.011 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 9.962886e-02 | 1.002 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 9.962886e-02 | 1.002 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 9.963588e-02 | 1.002 | 0 | 0 |
| Interactions of Tat with host cellular proteins | R-HSA-176034 | 1.286304e-01 | 0.891 | 0 | 0 |
| Defective SLC4A1 causes hereditary spherocytosis type 4 (HSP4), distal renal tubular acidosis (dRTA) and dRTA with hemolytic anemia (dRTA-HA) | R-HSA-5619050 | 1.286304e-01 | 0.891 | 0 | 0 |
| Defective SLC6A2 causes orthostatic intolerance (OI) | R-HSA-5619109 | 1.286304e-01 | 0.891 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 1.058983e-01 | 0.975 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 1.207285e-01 | 0.918 | 0 | 0 |
| Regulation of CDH11 mRNA translation by microRNAs | R-HSA-9759811 | 1.360284e-01 | 0.866 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 1.517261e-01 | 0.819 | 0 | 0 |
| PI3K events in ERBB4 signaling | R-HSA-1250342 | 1.517261e-01 | 0.819 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 1.289554e-01 | 0.890 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 1.289554e-01 | 0.890 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 1.393000e-01 | 0.856 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 1.219229e-01 | 0.914 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 1.015903e-01 | 0.993 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 1.154205e-01 | 0.938 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 1.141530e-01 | 0.943 | 0 | 0 |
| Proton-coupled monocarboxylate transport | R-HSA-433692 | 1.517261e-01 | 0.819 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 1.499133e-01 | 0.824 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 1.272959e-01 | 0.895 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 1.207285e-01 | 0.918 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 1.297877e-01 | 0.887 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 1.398270e-01 | 0.854 | 0 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 1.058983e-01 | 0.975 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 1.377334e-01 | 0.861 | 0 | 0 |
| Transport of connexins along the secretory pathway | R-HSA-190827 | 1.286304e-01 | 0.891 | 0 | 0 |
| Estrogen-stimulated signaling through PRKCZ | R-HSA-9634635 | 1.058983e-01 | 0.975 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 1.058983e-01 | 0.975 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 1.180153e-01 | 0.928 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 1.011913e-01 | 0.995 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 1.117125e-01 | 0.952 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 1.041993e-01 | 0.982 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 1.058983e-01 | 0.975 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 1.297877e-01 | 0.887 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 1.302941e-01 | 0.885 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 1.058983e-01 | 0.975 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 1.289554e-01 | 0.890 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 1.192305e-01 | 0.924 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 1.418612e-01 | 0.848 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 1.448034e-01 | 0.839 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 1.190749e-01 | 0.924 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 1.297877e-01 | 0.887 | 0 | 0 |
| Inhibition of membrane repair | R-HSA-9635644 | 1.286304e-01 | 0.891 | 0 | 0 |
| Oligomerization of connexins into connexons | R-HSA-190704 | 1.286304e-01 | 0.891 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 1.063842e-01 | 0.973 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 1.461222e-01 | 0.835 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 1.207285e-01 | 0.918 | 0 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 1.360284e-01 | 0.866 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 1.403070e-01 | 0.853 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 1.199298e-01 | 0.921 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 1.270927e-01 | 0.896 | 1 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 1.091520e-01 | 0.962 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 1.378570e-01 | 0.861 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 1.041993e-01 | 0.982 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 1.281455e-01 | 0.892 | 0 | 0 |
| Regulation of the apoptosome activity | R-HSA-9627069 | 1.207285e-01 | 0.918 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 1.289554e-01 | 0.890 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 1.360284e-01 | 0.866 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 1.289554e-01 | 0.890 | 0 | 0 |
| Immune System | R-HSA-168256 | 1.360667e-01 | 0.866 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 1.216924e-01 | 0.915 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 1.117125e-01 | 0.952 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 1.117125e-01 | 0.952 | 0 | 0 |
| Formation of apoptosome | R-HSA-111458 | 1.207285e-01 | 0.918 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 1.517261e-01 | 0.819 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 1.499133e-01 | 0.824 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 1.492532e-01 | 0.826 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 1.518778e-01 | 0.819 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 1.518778e-01 | 0.819 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 1.526098e-01 | 0.816 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 1.587355e-01 | 0.799 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 1.589353e-01 | 0.799 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 1.607757e-01 | 0.794 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 1.607757e-01 | 0.794 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 1.632110e-01 | 0.787 | 0 | 0 |
| RUNX3 regulates RUNX1-mediated transcription | R-HSA-8951911 | 1.677239e-01 | 0.775 | 0 | 0 |
| TGFBR1 LBD Mutants in Cancer | R-HSA-3656535 | 1.677239e-01 | 0.775 | 0 | 0 |
| Glycogen storage disease type 0 (muscle GYS1) | R-HSA-3828062 | 1.677239e-01 | 0.775 | 0 | 0 |
| Defective SLC6A5 causes hyperekplexia 3 (HKPX3) | R-HSA-5619089 | 1.677239e-01 | 0.775 | 0 | 0 |
| Signaling by RAS GAP mutants | R-HSA-9753510 | 1.677239e-01 | 0.775 | 0 | 0 |
| Glycogen storage disease type XV (GYG1) | R-HSA-3814836 | 1.677239e-01 | 0.775 | 0 | 0 |
| mRNA Editing: A to I Conversion | R-HSA-75064 | 1.677239e-01 | 0.775 | 0 | 0 |
| C6 deamination of adenosine | R-HSA-75102 | 1.677239e-01 | 0.775 | 0 | 0 |
| tRNA-derived small RNA (tsRNA or tRNA-related fragment, tRF) biogenesis | R-HSA-9708296 | 1.677239e-01 | 0.775 | 0 | 0 |
| Erythrocytes take up oxygen and release carbon dioxide | R-HSA-1247673 | 1.677553e-01 | 0.775 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 1.677553e-01 | 0.775 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 1.677553e-01 | 0.775 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 1.677553e-01 | 0.775 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 1.681765e-01 | 0.774 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 1.718673e-01 | 0.765 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 1.718673e-01 | 0.765 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 1.718673e-01 | 0.765 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 1.719191e-01 | 0.765 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 1.739310e-01 | 0.760 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 1.739310e-01 | 0.760 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 1.739310e-01 | 0.760 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 1.785708e-01 | 0.748 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 1.785708e-01 | 0.748 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 1.794730e-01 | 0.746 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 1.799652e-01 | 0.745 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 1.809677e-01 | 0.742 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 1.809677e-01 | 0.742 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 1.815416e-01 | 0.741 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 1.821421e-01 | 0.740 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 1.831686e-01 | 0.737 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 1.831686e-01 | 0.737 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 1.831686e-01 | 0.737 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 1.840548e-01 | 0.735 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 1.840548e-01 | 0.735 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 1.840548e-01 | 0.735 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 1.840548e-01 | 0.735 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 1.840548e-01 | 0.735 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 1.875540e-01 | 0.727 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 2.050658e-01 | 0.688 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 2.050658e-01 | 0.688 | 0 | 0 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 2.050658e-01 | 0.688 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 2.407345e-01 | 0.618 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 2.407345e-01 | 0.618 | 0 | 0 |
| RUNX3 regulates BCL2L11 (BIM) transcription | R-HSA-8952158 | 2.407345e-01 | 0.618 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 2.407345e-01 | 0.618 | 0 | 0 |
| Defective F9 activation | R-HSA-9673221 | 2.748047e-01 | 0.561 | 0 | 0 |
| Enhanced binding of GP1BA variant to VWF multimer:collagen | R-HSA-9845620 | 2.748047e-01 | 0.561 | 0 | 0 |
| Defective binding of VWF variant to GPIb:IX:V | R-HSA-9846298 | 2.748047e-01 | 0.561 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 3.073481e-01 | 0.512 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 3.073481e-01 | 0.512 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 3.073481e-01 | 0.512 | 0 | 0 |
| Signaling by MAPK mutants | R-HSA-9652817 | 3.073481e-01 | 0.512 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 2.005682e-01 | 0.698 | 0 | 0 |
| Small interfering RNA (siRNA) biogenesis | R-HSA-426486 | 3.384331e-01 | 0.471 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 3.384331e-01 | 0.471 | 0 | 0 |
| Autointegration results in viral DNA circles | R-HSA-177539 | 3.384331e-01 | 0.471 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 3.384331e-01 | 0.471 | 0 | 0 |
| Competing endogenous RNAs (ceRNAs) regulate PTEN translation | R-HSA-8948700 | 2.172436e-01 | 0.663 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 2.172436e-01 | 0.663 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 2.172436e-01 | 0.663 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 2.172436e-01 | 0.663 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 2.340333e-01 | 0.631 | 0 | 0 |
| RUNX3 Regulates Immune Response and Cell Migration | R-HSA-8949275 | 3.681247e-01 | 0.434 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 3.681247e-01 | 0.434 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 3.681247e-01 | 0.434 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 2.677845e-01 | 0.572 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 2.677845e-01 | 0.572 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 3.015145e-01 | 0.521 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 3.182899e-01 | 0.497 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 3.182899e-01 | 0.497 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 3.349678e-01 | 0.475 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 3.349678e-01 | 0.475 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 3.349678e-01 | 0.475 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 2.788968e-01 | 0.555 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 3.515233e-01 | 0.454 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 3.515233e-01 | 0.454 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 2.912671e-01 | 0.536 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 2.912671e-01 | 0.536 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 3.679337e-01 | 0.434 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 3.161033e-01 | 0.500 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 3.285411e-01 | 0.483 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 2.112671e-01 | 0.675 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 2.177585e-01 | 0.662 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 3.283607e-01 | 0.484 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 2.720027e-01 | 0.565 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 2.157505e-01 | 0.666 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 2.650239e-01 | 0.577 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 3.679337e-01 | 0.434 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 2.665783e-01 | 0.574 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 2.673016e-01 | 0.573 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 3.338176e-01 | 0.476 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 2.278532e-01 | 0.642 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 2.172436e-01 | 0.663 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 2.340333e-01 | 0.631 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 2.508936e-01 | 0.601 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 3.679337e-01 | 0.434 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 2.748047e-01 | 0.561 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 3.681247e-01 | 0.434 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 2.508936e-01 | 0.601 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 2.421588e-01 | 0.616 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 1.971204e-01 | 0.705 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 3.682777e-01 | 0.434 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 2.846692e-01 | 0.546 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 3.679337e-01 | 0.434 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 2.982622e-01 | 0.525 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 2.982622e-01 | 0.525 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 2.005682e-01 | 0.698 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 2.172436e-01 | 0.663 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 2.677845e-01 | 0.572 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 2.846692e-01 | 0.546 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 3.220338e-01 | 0.492 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 2.720240e-01 | 0.565 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 2.633890e-01 | 0.579 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 2.748047e-01 | 0.561 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 3.681247e-01 | 0.434 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 2.177585e-01 | 0.662 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 2.828539e-01 | 0.548 | 0 | 0 |
| Loss of Function of TGFBR1 in Cancer | R-HSA-3656534 | 2.748047e-01 | 0.561 | 0 | 0 |
| Pentose phosphate pathway disease | R-HSA-6791465 | 3.073481e-01 | 0.512 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 2.340333e-01 | 0.631 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 2.340333e-01 | 0.631 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 3.681247e-01 | 0.434 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 2.508936e-01 | 0.601 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 2.846692e-01 | 0.546 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 3.349678e-01 | 0.475 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 3.515233e-01 | 0.454 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 3.679337e-01 | 0.434 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 3.161033e-01 | 0.500 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 3.360850e-01 | 0.474 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 3.015145e-01 | 0.521 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 2.474047e-01 | 0.607 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 2.548188e-01 | 0.594 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 2.833451e-01 | 0.548 | 0 | 0 |
| Neurofascin interactions | R-HSA-447043 | 3.384331e-01 | 0.471 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 2.638981e-01 | 0.579 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 2.132890e-01 | 0.671 | 0 | 0 |
| Defects of platelet adhesion to exposed collagen | R-HSA-9823587 | 3.073481e-01 | 0.512 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 3.679337e-01 | 0.434 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 3.533902e-01 | 0.452 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 2.583198e-01 | 0.588 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 3.088888e-01 | 0.510 | 0 | 0 |
| Regulation of BACH1 activity | R-HSA-9708530 | 2.340333e-01 | 0.631 | 0 | 0 |
| Erythrocytes take up carbon dioxide and release oxygen | R-HSA-1237044 | 3.015145e-01 | 0.521 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 3.075579e-01 | 0.512 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 3.427374e-01 | 0.465 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 2.213002e-01 | 0.655 | 0 | 0 |
| O2/CO2 exchange in erythrocytes | R-HSA-1480926 | 3.015145e-01 | 0.521 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 2.087201e-01 | 0.680 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 2.061628e-01 | 0.686 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 3.781232e-01 | 0.422 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 2.981236e-01 | 0.526 | 0 | 0 |
| TNFR1-mediated ceramide production | R-HSA-5626978 | 2.407345e-01 | 0.618 | 0 | 0 |
| Integration of viral DNA into host genomic DNA | R-HSA-175567 | 3.384331e-01 | 0.471 | 0 | 0 |
| Synthesis of PIPs in the nucleus | R-HSA-8847453 | 3.681247e-01 | 0.434 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 2.508936e-01 | 0.601 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 2.300907e-01 | 0.638 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 2.543269e-01 | 0.595 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 2.665783e-01 | 0.574 | 0 | 0 |
| S Phase | R-HSA-69242 | 2.364207e-01 | 0.626 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 2.427330e-01 | 0.615 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 2.421588e-01 | 0.616 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 2.340333e-01 | 0.631 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 2.573145e-01 | 0.590 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 3.679337e-01 | 0.434 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 2.096261e-01 | 0.679 | 0 | 0 |
| Malate-aspartate shuttle | R-HSA-9856872 | 2.005682e-01 | 0.698 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 2.665783e-01 | 0.574 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 2.580959e-01 | 0.588 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 2.855669e-01 | 0.544 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 2.260103e-01 | 0.646 | 0 | 0 |
| The NLRP1 inflammasome | R-HSA-844455 | 2.050658e-01 | 0.688 | 0 | 0 |
| NrCAM interactions | R-HSA-447038 | 2.748047e-01 | 0.561 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 2.340333e-01 | 0.631 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 3.681247e-01 | 0.434 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 3.681247e-01 | 0.434 | 0 | 0 |
| Ribavirin ADME | R-HSA-9755088 | 3.515233e-01 | 0.454 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 3.533902e-01 | 0.452 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 2.132890e-01 | 0.671 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 2.580959e-01 | 0.588 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 3.787048e-01 | 0.422 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 2.673016e-01 | 0.573 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 3.285411e-01 | 0.483 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 2.865811e-01 | 0.543 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 3.073481e-01 | 0.512 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 3.073481e-01 | 0.512 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 3.384331e-01 | 0.471 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 3.681247e-01 | 0.434 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 3.681247e-01 | 0.434 | 0 | 0 |
| Synthesis of PG | R-HSA-1483148 | 2.508936e-01 | 0.601 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 3.734158e-01 | 0.428 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 3.154288e-01 | 0.501 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 2.204992e-01 | 0.657 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 2.677845e-01 | 0.572 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 3.071007e-01 | 0.513 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 3.386489e-01 | 0.470 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 2.364207e-01 | 0.626 | 1 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 3.039397e-01 | 0.517 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 2.340333e-01 | 0.631 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 2.253523e-01 | 0.647 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 2.010134e-01 | 0.697 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 3.386489e-01 | 0.470 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 2.729969e-01 | 0.564 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 3.427728e-01 | 0.465 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 2.527815e-01 | 0.597 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 3.384331e-01 | 0.471 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 2.573145e-01 | 0.590 | 0 | 0 |
| Nephron development | R-HSA-9831926 | 2.846692e-01 | 0.546 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 3.039397e-01 | 0.517 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 2.508936e-01 | 0.601 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 3.679337e-01 | 0.434 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 2.403168e-01 | 0.619 | 0 | 0 |
| Signaling by Activin | R-HSA-1502540 | 2.172436e-01 | 0.663 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 3.515233e-01 | 0.454 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 3.796406e-01 | 0.421 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 3.386489e-01 | 0.470 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 2.172436e-01 | 0.663 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 2.976387e-01 | 0.526 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 2.668695e-01 | 0.574 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 2.070552e-01 | 0.684 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 2.817975e-01 | 0.550 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 2.846692e-01 | 0.546 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 3.798365e-01 | 0.420 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 3.798365e-01 | 0.420 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 3.798365e-01 | 0.420 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 3.798365e-01 | 0.420 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 3.798365e-01 | 0.420 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 3.798365e-01 | 0.420 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 3.841788e-01 | 0.415 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 3.841788e-01 | 0.415 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 3.841788e-01 | 0.415 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 3.841788e-01 | 0.415 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 3.844323e-01 | 0.415 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 3.844323e-01 | 0.415 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 3.844323e-01 | 0.415 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 3.844323e-01 | 0.415 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 3.847710e-01 | 0.415 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 3.876913e-01 | 0.412 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 3.904179e-01 | 0.408 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 3.964855e-01 | 0.402 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 3.964855e-01 | 0.402 | 0 | 0 |
| Myoclonic epilepsy of Lafora | R-HSA-3785653 | 3.964855e-01 | 0.402 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 3.964855e-01 | 0.402 | 0 | 0 |
| Nef mediated downregulation of MHC class I complex cell surface expression | R-HSA-164940 | 3.964855e-01 | 0.402 | 0 | 0 |
| Negative regulation of activity of TFAP2 (AP-2) family transcription factors | R-HSA-8866904 | 3.964855e-01 | 0.402 | 0 | 0 |
| Activation of RAS in B cells | R-HSA-1169092 | 3.964855e-01 | 0.402 | 0 | 0 |
| phospho-PLA2 pathway | R-HSA-111995 | 3.964855e-01 | 0.402 | 0 | 0 |
| SLC-mediated bile acid transport | R-HSA-9958517 | 3.964855e-01 | 0.402 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 3.964855e-01 | 0.402 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 3.964855e-01 | 0.402 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 3.977163e-01 | 0.400 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 3.979206e-01 | 0.400 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 4.002405e-01 | 0.398 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 4.002405e-01 | 0.398 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 4.002405e-01 | 0.398 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 4.002405e-01 | 0.398 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 4.003523e-01 | 0.398 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 4.003523e-01 | 0.398 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 4.005883e-01 | 0.397 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 4.026511e-01 | 0.395 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 4.104083e-01 | 0.387 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 4.104083e-01 | 0.387 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 4.148129e-01 | 0.382 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 4.148129e-01 | 0.382 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 4.148129e-01 | 0.382 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 4.161024e-01 | 0.381 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 4.161024e-01 | 0.381 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 4.235129e-01 | 0.373 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 4.235751e-01 | 0.373 | 0 | 0 |
| MAPK1 (ERK2) activation | R-HSA-112411 | 4.235751e-01 | 0.373 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 4.235751e-01 | 0.373 | 0 | 0 |
| mRNA Editing | R-HSA-75072 | 4.235751e-01 | 0.373 | 0 | 0 |
| Regulation of signaling by NODAL | R-HSA-1433617 | 4.235751e-01 | 0.373 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 4.235751e-01 | 0.373 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 4.235751e-01 | 0.373 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 4.235751e-01 | 0.373 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 4.317501e-01 | 0.365 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 4.317501e-01 | 0.365 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 4.317501e-01 | 0.365 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 4.319582e-01 | 0.365 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 4.319582e-01 | 0.365 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 4.319582e-01 | 0.365 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 4.325607e-01 | 0.364 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 4.325607e-01 | 0.364 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 4.327984e-01 | 0.364 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 4.388058e-01 | 0.358 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 4.388868e-01 | 0.358 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 4.388868e-01 | 0.358 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 4.471711e-01 | 0.350 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 4.471711e-01 | 0.350 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 4.471711e-01 | 0.350 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 4.471711e-01 | 0.350 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 4.471711e-01 | 0.350 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 4.488018e-01 | 0.348 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 4.494502e-01 | 0.347 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 4.494502e-01 | 0.347 | 0 | 0 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 4.494502e-01 | 0.347 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 4.494502e-01 | 0.347 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 4.494502e-01 | 0.347 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 4.494502e-01 | 0.347 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 4.494502e-01 | 0.347 | 0 | 0 |
| Defective factor IX causes hemophilia B | R-HSA-9668250 | 4.494502e-01 | 0.347 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 4.494502e-01 | 0.347 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 4.494502e-01 | 0.347 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 4.494502e-01 | 0.347 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 4.494502e-01 | 0.347 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 4.507823e-01 | 0.346 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 4.532051e-01 | 0.344 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 4.589326e-01 | 0.338 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 4.623540e-01 | 0.335 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 4.623540e-01 | 0.335 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 4.623540e-01 | 0.335 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 4.625734e-01 | 0.335 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 4.726137e-01 | 0.325 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 4.741653e-01 | 0.324 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 4.741653e-01 | 0.324 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 4.741653e-01 | 0.324 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 4.741653e-01 | 0.324 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 4.741653e-01 | 0.324 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 4.741653e-01 | 0.324 | 0 | 0 |
| Dissolution of Fibrin Clot | R-HSA-75205 | 4.741653e-01 | 0.324 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 4.742531e-01 | 0.324 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 4.772893e-01 | 0.321 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 4.772893e-01 | 0.321 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 4.772893e-01 | 0.321 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 4.772893e-01 | 0.321 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 4.772893e-01 | 0.321 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 4.772893e-01 | 0.321 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 4.772893e-01 | 0.321 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 4.796041e-01 | 0.319 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 4.804884e-01 | 0.318 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 4.807382e-01 | 0.318 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 4.883273e-01 | 0.311 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 4.883273e-01 | 0.311 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 4.919686e-01 | 0.308 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 4.919686e-01 | 0.308 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 4.919686e-01 | 0.308 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 4.919686e-01 | 0.308 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 4.930509e-01 | 0.307 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 4.977724e-01 | 0.303 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 4.977724e-01 | 0.303 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 4.977724e-01 | 0.303 | 0 | 0 |
| Viral RNP Complexes in the Host Cell Nucleus | R-HSA-168330 | 4.977724e-01 | 0.303 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 4.977724e-01 | 0.303 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 4.977724e-01 | 0.303 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 5.063847e-01 | 0.296 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 5.116056e-01 | 0.291 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 5.193487e-01 | 0.285 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 5.196345e-01 | 0.284 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 5.197344e-01 | 0.284 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 5.197344e-01 | 0.284 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 5.198883e-01 | 0.284 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 5.203210e-01 | 0.284 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 5.203210e-01 | 0.284 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 5.203210e-01 | 0.284 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 5.203210e-01 | 0.284 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 5.203210e-01 | 0.284 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 5.203210e-01 | 0.284 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 5.203210e-01 | 0.284 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 5.203210e-01 | 0.284 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 5.203210e-01 | 0.284 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 5.203210e-01 | 0.284 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 5.203210e-01 | 0.284 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 5.203210e-01 | 0.284 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 5.203210e-01 | 0.284 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 5.203210e-01 | 0.284 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 5.205317e-01 | 0.284 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 5.205317e-01 | 0.284 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 5.307689e-01 | 0.275 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 5.327465e-01 | 0.273 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 5.344048e-01 | 0.272 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 5.344048e-01 | 0.272 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 5.344048e-01 | 0.272 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 5.344048e-01 | 0.272 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 5.344048e-01 | 0.272 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 5.344048e-01 | 0.272 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 5.359426e-01 | 0.271 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 5.381402e-01 | 0.269 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 5.416598e-01 | 0.266 | 0 | 0 |
| Processing of SMDT1 | R-HSA-8949664 | 5.418585e-01 | 0.266 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 5.418585e-01 | 0.266 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 5.418585e-01 | 0.266 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 5.418585e-01 | 0.266 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 5.418585e-01 | 0.266 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 5.480000e-01 | 0.261 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 5.480000e-01 | 0.261 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 5.565535e-01 | 0.254 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 5.565535e-01 | 0.254 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 5.565535e-01 | 0.254 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 5.613142e-01 | 0.251 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 5.613142e-01 | 0.251 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 5.613142e-01 | 0.251 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 5.613142e-01 | 0.251 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 5.613142e-01 | 0.251 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 5.613142e-01 | 0.251 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 5.624303e-01 | 0.250 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 5.624303e-01 | 0.250 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 5.624303e-01 | 0.250 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 5.624303e-01 | 0.250 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 5.624303e-01 | 0.250 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 5.624303e-01 | 0.250 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 5.624303e-01 | 0.250 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 5.629961e-01 | 0.249 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 5.629961e-01 | 0.249 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 5.629961e-01 | 0.249 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 5.678157e-01 | 0.246 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 5.743454e-01 | 0.241 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 5.745661e-01 | 0.241 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 5.820795e-01 | 0.235 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 5.820795e-01 | 0.235 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 5.820795e-01 | 0.235 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 5.820795e-01 | 0.235 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 5.820795e-01 | 0.235 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 5.820795e-01 | 0.235 | 0 | 0 |
| Lysosphingolipid and LPA receptors | R-HSA-419408 | 5.820795e-01 | 0.235 | 0 | 0 |
| Biotin transport and metabolism | R-HSA-196780 | 5.820795e-01 | 0.235 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 5.820795e-01 | 0.235 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 5.820795e-01 | 0.235 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 5.820795e-01 | 0.235 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 5.820795e-01 | 0.235 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 5.820795e-01 | 0.235 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 5.820795e-01 | 0.235 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 5.837171e-01 | 0.234 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 5.837171e-01 | 0.234 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 5.837171e-01 | 0.234 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 5.870921e-01 | 0.231 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 5.870921e-01 | 0.231 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 5.870921e-01 | 0.231 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 5.870921e-01 | 0.231 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 5.870921e-01 | 0.231 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 5.870921e-01 | 0.231 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 5.870921e-01 | 0.231 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 5.870921e-01 | 0.231 | 0 | 0 |
| Translation | R-HSA-72766 | 5.884937e-01 | 0.230 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 5.960716e-01 | 0.225 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 5.995536e-01 | 0.222 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 6.001217e-01 | 0.222 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 6.008475e-01 | 0.221 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 6.008475e-01 | 0.221 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 6.008475e-01 | 0.221 | 0 | 0 |
| Fructose catabolism | R-HSA-70350 | 6.008475e-01 | 0.221 | 0 | 0 |
| Differentiation of naive CD+ T cells to T helper 1 cells (Th1 cells) | R-HSA-9942503 | 6.008475e-01 | 0.221 | 0 | 0 |
| Differentiation of T cells | R-HSA-9945266 | 6.008475e-01 | 0.221 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 6.008475e-01 | 0.221 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 6.075494e-01 | 0.216 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 6.117297e-01 | 0.213 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 6.117297e-01 | 0.213 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 6.117297e-01 | 0.213 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 6.136014e-01 | 0.212 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 6.187738e-01 | 0.208 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 6.187738e-01 | 0.208 | 0 | 0 |
| Biosynthesis of maresin-like SPMs | R-HSA-9027307 | 6.187738e-01 | 0.208 | 0 | 0 |
| Heme assimilation | R-HSA-9927020 | 6.187738e-01 | 0.208 | 0 | 0 |
| Coenzyme A biosynthesis | R-HSA-196783 | 6.187738e-01 | 0.208 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 6.187738e-01 | 0.208 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 6.187738e-01 | 0.208 | 0 | 0 |
| Defects of contact activation system (CAS) and kallikrein/kinin system (KKS) | R-HSA-9651496 | 6.187738e-01 | 0.208 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 6.232361e-01 | 0.205 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 6.236210e-01 | 0.205 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 6.236210e-01 | 0.205 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 6.261995e-01 | 0.203 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 6.324043e-01 | 0.199 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 6.352284e-01 | 0.197 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 6.352284e-01 | 0.197 | 0 | 0 |
| Synthesis of PIPs at the late endosome membrane | R-HSA-1660517 | 6.358960e-01 | 0.197 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 6.358960e-01 | 0.197 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 6.358960e-01 | 0.197 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 6.358960e-01 | 0.197 | 0 | 0 |
| Choline catabolism | R-HSA-6798163 | 6.358960e-01 | 0.197 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 6.358960e-01 | 0.197 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 6.358960e-01 | 0.197 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 6.420081e-01 | 0.192 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 6.420081e-01 | 0.192 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 6.444561e-01 | 0.191 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 6.465536e-01 | 0.189 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 6.465536e-01 | 0.189 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 6.465536e-01 | 0.189 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 6.472642e-01 | 0.189 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 6.492174e-01 | 0.188 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 6.510963e-01 | 0.186 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 6.522502e-01 | 0.186 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 6.522502e-01 | 0.186 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 6.522502e-01 | 0.186 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 6.522502e-01 | 0.186 | 0 | 0 |
| Organic anion transport by SLC5/17/25 transporters | R-HSA-428643 | 6.522502e-01 | 0.186 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 6.522502e-01 | 0.186 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 6.522502e-01 | 0.186 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 6.522502e-01 | 0.186 | 0 | 0 |
| Vitamin D (calciferol) metabolism | R-HSA-196791 | 6.522502e-01 | 0.186 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 6.522502e-01 | 0.186 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 6.540406e-01 | 0.184 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 6.575983e-01 | 0.182 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 6.575983e-01 | 0.182 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 6.575983e-01 | 0.182 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 6.575983e-01 | 0.182 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 6.575983e-01 | 0.182 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 6.601116e-01 | 0.180 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 6.657506e-01 | 0.177 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 6.667985e-01 | 0.176 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 6.678708e-01 | 0.175 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 6.678708e-01 | 0.175 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 6.678708e-01 | 0.175 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 6.678708e-01 | 0.175 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 6.678708e-01 | 0.175 | 0 | 0 |
| Diseases of hemostasis | R-HSA-9671793 | 6.678708e-01 | 0.175 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 6.678708e-01 | 0.175 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 6.678708e-01 | 0.175 | 0 | 0 |
| Strand-asynchronous mitochondrial DNA replication | R-HSA-9913635 | 6.678708e-01 | 0.175 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 6.678708e-01 | 0.175 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 6.683651e-01 | 0.175 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 6.689118e-01 | 0.175 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 6.689118e-01 | 0.175 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 6.704375e-01 | 0.174 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 6.723669e-01 | 0.172 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 6.733407e-01 | 0.172 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 6.775442e-01 | 0.169 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 6.775442e-01 | 0.169 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 6.788564e-01 | 0.168 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 6.788564e-01 | 0.168 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 6.804585e-01 | 0.167 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 6.827906e-01 | 0.166 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 6.827906e-01 | 0.166 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 6.827906e-01 | 0.166 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 6.827906e-01 | 0.166 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 6.827906e-01 | 0.166 | 0 | 0 |
| Creatine metabolism | R-HSA-71288 | 6.827906e-01 | 0.166 | 0 | 0 |
| Common Pathway of Fibrin Clot Formation | R-HSA-140875 | 6.827906e-01 | 0.166 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 6.827906e-01 | 0.166 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 6.827906e-01 | 0.166 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 6.827906e-01 | 0.166 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 6.856412e-01 | 0.164 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 6.890754e-01 | 0.162 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 6.890754e-01 | 0.162 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 6.890754e-01 | 0.162 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 6.917563e-01 | 0.160 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 6.943066e-01 | 0.158 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 6.943066e-01 | 0.158 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 6.970411e-01 | 0.157 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 6.970411e-01 | 0.157 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 6.970411e-01 | 0.157 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 6.970411e-01 | 0.157 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 6.970411e-01 | 0.157 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 6.970411e-01 | 0.157 | 0 | 0 |
| Intrinsic Pathway of Fibrin Clot Formation | R-HSA-140837 | 6.970411e-01 | 0.157 | 0 | 0 |
| PD-L1(CD274) glycosylation and translocation to plasma membrane | R-HSA-9931295 | 6.970411e-01 | 0.157 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 6.970411e-01 | 0.157 | 0 | 0 |
| Prevention of phagosomal-lysosomal fusion | R-HSA-9636383 | 6.970411e-01 | 0.157 | 0 | 0 |
| Disease | R-HSA-1643685 | 6.984517e-01 | 0.156 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 6.990253e-01 | 0.156 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 6.990253e-01 | 0.156 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 6.990253e-01 | 0.156 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 7.024375e-01 | 0.153 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 7.024375e-01 | 0.153 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 7.051643e-01 | 0.152 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 7.087097e-01 | 0.150 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 7.087097e-01 | 0.150 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 7.087097e-01 | 0.150 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 7.087097e-01 | 0.150 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 7.087097e-01 | 0.150 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 7.087097e-01 | 0.150 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 7.090585e-01 | 0.149 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 7.104026e-01 | 0.148 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 7.106522e-01 | 0.148 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 7.106522e-01 | 0.148 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 7.106522e-01 | 0.148 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 7.106522e-01 | 0.148 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 7.106522e-01 | 0.148 | 0 | 0 |
| Molybdenum cofactor biosynthesis | R-HSA-947581 | 7.106522e-01 | 0.148 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 7.106522e-01 | 0.148 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 7.106522e-01 | 0.148 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 7.147867e-01 | 0.146 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 7.176235e-01 | 0.144 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 7.176235e-01 | 0.144 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 7.181324e-01 | 0.144 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 7.181324e-01 | 0.144 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 7.182027e-01 | 0.144 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 7.182027e-01 | 0.144 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 7.206884e-01 | 0.142 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 7.236526e-01 | 0.140 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 7.236526e-01 | 0.140 | 0 | 0 |
| Fructose metabolism | R-HSA-5652084 | 7.236526e-01 | 0.140 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 7.236526e-01 | 0.140 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 7.236526e-01 | 0.140 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 7.236526e-01 | 0.140 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 7.237112e-01 | 0.140 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 7.239800e-01 | 0.140 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 7.258388e-01 | 0.139 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 7.297043e-01 | 0.137 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 7.297323e-01 | 0.137 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 7.297323e-01 | 0.137 | 0 | 0 |
| Biosynthesis of maresins | R-HSA-9018682 | 7.360696e-01 | 0.133 | 0 | 0 |
| Carnitine shuttle | R-HSA-200425 | 7.360696e-01 | 0.133 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 7.362083e-01 | 0.133 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 7.406240e-01 | 0.130 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 7.414074e-01 | 0.130 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 7.414074e-01 | 0.130 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 7.426312e-01 | 0.129 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 7.448701e-01 | 0.128 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 7.448701e-01 | 0.128 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 7.477758e-01 | 0.126 | 0 | 0 |
| CYP2E1 reactions | R-HSA-211999 | 7.479294e-01 | 0.126 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 7.479294e-01 | 0.126 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 7.479294e-01 | 0.126 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 7.479294e-01 | 0.126 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 7.479294e-01 | 0.126 | 0 | 0 |
| Assembly of active LPL and LIPC lipase complexes | R-HSA-8963889 | 7.479294e-01 | 0.126 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 7.479294e-01 | 0.126 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 7.479294e-01 | 0.126 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 7.547690e-01 | 0.122 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 7.547690e-01 | 0.122 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 7.592570e-01 | 0.120 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 7.592570e-01 | 0.120 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 7.592570e-01 | 0.120 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 7.592570e-01 | 0.120 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 7.592570e-01 | 0.120 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 7.592570e-01 | 0.120 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 7.592570e-01 | 0.120 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 7.610943e-01 | 0.119 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 7.614632e-01 | 0.118 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 7.614632e-01 | 0.118 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 7.614632e-01 | 0.118 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 7.614632e-01 | 0.118 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 7.690251e-01 | 0.114 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 7.694037e-01 | 0.114 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 7.694037e-01 | 0.114 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 7.694037e-01 | 0.114 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 7.700762e-01 | 0.113 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 7.700762e-01 | 0.113 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 7.700762e-01 | 0.113 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 7.700762e-01 | 0.113 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 7.700762e-01 | 0.113 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 7.700762e-01 | 0.113 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 7.700762e-01 | 0.113 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 7.771130e-01 | 0.110 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 7.785129e-01 | 0.109 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 7.785129e-01 | 0.109 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 7.785129e-01 | 0.109 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 7.804098e-01 | 0.108 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 7.804098e-01 | 0.108 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 7.804098e-01 | 0.108 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 7.804098e-01 | 0.108 | 0 | 0 |
| Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane | R-HSA-83936 | 7.804098e-01 | 0.108 | 0 | 0 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 7.804098e-01 | 0.108 | 0 | 0 |
| Synthesis of bile acids and bile salts via 27-hydroxycholesterol | R-HSA-193807 | 7.804098e-01 | 0.108 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 7.804098e-01 | 0.108 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 7.804098e-01 | 0.108 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 7.804098e-01 | 0.108 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 7.845958e-01 | 0.105 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 7.845958e-01 | 0.105 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 7.845958e-01 | 0.105 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 7.861336e-01 | 0.105 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 7.902796e-01 | 0.102 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 7.902796e-01 | 0.102 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 7.902796e-01 | 0.102 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 7.902796e-01 | 0.102 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 7.902796e-01 | 0.102 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 7.902796e-01 | 0.102 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 7.918570e-01 | 0.101 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 7.918570e-01 | 0.101 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 7.934959e-01 | 0.100 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 7.989012e-01 | 0.098 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 7.991357e-01 | 0.097 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 7.997063e-01 | 0.097 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 7.997063e-01 | 0.097 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 8.002853e-01 | 0.097 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 8.057334e-01 | 0.094 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 8.084586e-01 | 0.092 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 8.087099e-01 | 0.092 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 8.087099e-01 | 0.092 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 8.087099e-01 | 0.092 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 8.087099e-01 | 0.092 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 8.087099e-01 | 0.092 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 8.108683e-01 | 0.091 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 8.123584e-01 | 0.090 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 8.123584e-01 | 0.090 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 8.123584e-01 | 0.090 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 8.141364e-01 | 0.089 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 8.141364e-01 | 0.089 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 8.163782e-01 | 0.088 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 8.173092e-01 | 0.088 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 8.173092e-01 | 0.088 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 8.173092e-01 | 0.088 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 8.173092e-01 | 0.088 | 0 | 0 |
| Aspartate and asparagine metabolism | R-HSA-8963693 | 8.173092e-01 | 0.088 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 8.173092e-01 | 0.088 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 8.184468e-01 | 0.087 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 8.187809e-01 | 0.087 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 8.187809e-01 | 0.087 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 8.247708e-01 | 0.084 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 8.255225e-01 | 0.083 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 8.255225e-01 | 0.083 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 8.269896e-01 | 0.082 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 8.302614e-01 | 0.081 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 8.310378e-01 | 0.080 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 8.310378e-01 | 0.080 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 8.333670e-01 | 0.079 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 8.333670e-01 | 0.079 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 8.333670e-01 | 0.079 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 8.359820e-01 | 0.078 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 8.370718e-01 | 0.077 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 8.382986e-01 | 0.077 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 8.402314e-01 | 0.076 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 8.408593e-01 | 0.075 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 8.408593e-01 | 0.075 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 8.408593e-01 | 0.075 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 8.408593e-01 | 0.075 | 0 | 0 |
| Glutamate and glutamine metabolism | R-HSA-8964539 | 8.408593e-01 | 0.075 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 8.425423e-01 | 0.074 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 8.466435e-01 | 0.072 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 8.480151e-01 | 0.072 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 8.480151e-01 | 0.072 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 8.480151e-01 | 0.072 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 8.480151e-01 | 0.072 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 8.480151e-01 | 0.072 | 0 | 0 |
| RA biosynthesis pathway | R-HSA-5365859 | 8.480151e-01 | 0.072 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 8.480151e-01 | 0.072 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 8.480151e-01 | 0.072 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 8.480151e-01 | 0.072 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 8.480151e-01 | 0.072 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 8.499732e-01 | 0.071 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 8.548496e-01 | 0.068 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 8.548496e-01 | 0.068 | 0 | 0 |
| Synthesis of bile acids and bile salts via 24-hydroxycholesterol | R-HSA-193775 | 8.548496e-01 | 0.068 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 8.557231e-01 | 0.068 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 8.584699e-01 | 0.066 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 8.584699e-01 | 0.066 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 8.600842e-01 | 0.065 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 8.613772e-01 | 0.065 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 8.613772e-01 | 0.065 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 8.629431e-01 | 0.064 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 8.633590e-01 | 0.064 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 8.676115e-01 | 0.062 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 8.676115e-01 | 0.062 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 8.676115e-01 | 0.062 | 0 | 0 |
| Metabolism of folate and pterines | R-HSA-196757 | 8.676115e-01 | 0.062 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 8.729118e-01 | 0.059 | 0 | 0 |
| tRNA processing in the mitochondrion | R-HSA-6785470 | 8.735659e-01 | 0.059 | 0 | 0 |
| Depurination | R-HSA-73927 | 8.735659e-01 | 0.059 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 8.735659e-01 | 0.059 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 8.735659e-01 | 0.059 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 8.735659e-01 | 0.059 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 8.763921e-01 | 0.057 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 8.792528e-01 | 0.056 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 8.792528e-01 | 0.056 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 8.792528e-01 | 0.056 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 8.792528e-01 | 0.056 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 8.792528e-01 | 0.056 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 8.801965e-01 | 0.055 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 8.809656e-01 | 0.055 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 8.839449e-01 | 0.054 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 8.839449e-01 | 0.054 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 8.839449e-01 | 0.054 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 8.846842e-01 | 0.053 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 8.846842e-01 | 0.053 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 8.846842e-01 | 0.053 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 8.846842e-01 | 0.053 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 8.846842e-01 | 0.053 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 8.846842e-01 | 0.053 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 8.846842e-01 | 0.053 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 8.846842e-01 | 0.053 | 0 | 0 |
| rRNA processing in the mitochondrion | R-HSA-8868766 | 8.846842e-01 | 0.053 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 8.846842e-01 | 0.053 | 0 | 0 |
| Mitochondrial tRNA aminoacylation | R-HSA-379726 | 8.846842e-01 | 0.053 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 8.859861e-01 | 0.053 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 8.866137e-01 | 0.052 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 8.898717e-01 | 0.051 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 8.898717e-01 | 0.051 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 8.898717e-01 | 0.051 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 8.900598e-01 | 0.051 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 8.925643e-01 | 0.049 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 8.939982e-01 | 0.049 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 8.939982e-01 | 0.049 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 8.939982e-01 | 0.049 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 8.948261e-01 | 0.048 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 8.948261e-01 | 0.048 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 8.948261e-01 | 0.048 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 8.995578e-01 | 0.046 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 8.995578e-01 | 0.046 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 8.995578e-01 | 0.046 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 8.995578e-01 | 0.046 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 9.014843e-01 | 0.045 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 9.050325e-01 | 0.043 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 9.050396e-01 | 0.043 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 9.083931e-01 | 0.042 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 9.083931e-01 | 0.042 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 9.083931e-01 | 0.042 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 9.125153e-01 | 0.040 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 9.125153e-01 | 0.040 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 9.125153e-01 | 0.040 | 0 | 0 |
| Degradation of cysteine and homocysteine | R-HSA-1614558 | 9.125153e-01 | 0.040 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 9.128631e-01 | 0.040 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 9.149990e-01 | 0.039 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 9.164522e-01 | 0.038 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 9.164522e-01 | 0.038 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 9.164522e-01 | 0.038 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 9.164522e-01 | 0.038 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 9.164522e-01 | 0.038 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.183355e-01 | 0.037 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 9.210848e-01 | 0.036 | 0 | 0 |
| Plasma lipoprotein remodeling | R-HSA-8963899 | 9.238031e-01 | 0.034 | 0 | 0 |
| Glyoxylate metabolism and glycine degradation | R-HSA-389661 | 9.272327e-01 | 0.033 | 0 | 0 |
| Chemokine receptors bind chemokines | R-HSA-380108 | 9.272327e-01 | 0.033 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 9.294492e-01 | 0.032 | 0 | 0 |
| Synthesis of Prostaglandins (PG) and Thromboxanes (TX) | R-HSA-2162123 | 9.305081e-01 | 0.031 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 9.305081e-01 | 0.031 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 9.306716e-01 | 0.031 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 9.336363e-01 | 0.030 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 9.336363e-01 | 0.030 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 9.336363e-01 | 0.030 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.351077e-01 | 0.029 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 9.366238e-01 | 0.028 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 9.391260e-01 | 0.027 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 9.394770e-01 | 0.027 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 9.394770e-01 | 0.027 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.415561e-01 | 0.026 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 9.422019e-01 | 0.026 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 9.448043e-01 | 0.025 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 9.478439e-01 | 0.023 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 9.478439e-01 | 0.023 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.483772e-01 | 0.023 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.486666e-01 | 0.023 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 9.496633e-01 | 0.022 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 9.496633e-01 | 0.022 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 9.516719e-01 | 0.022 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.516719e-01 | 0.022 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.536358e-01 | 0.021 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 9.561626e-01 | 0.019 | 0 | 0 |
| Signaling by Retinoic Acid | R-HSA-5362517 | 9.561626e-01 | 0.019 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 9.581371e-01 | 0.019 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 9.581371e-01 | 0.019 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 9.592313e-01 | 0.018 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 9.605278e-01 | 0.017 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 9.618237e-01 | 0.017 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 9.618237e-01 | 0.017 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 9.621100e-01 | 0.017 | 0 | 0 |
| Xenobiotics | R-HSA-211981 | 9.635436e-01 | 0.016 | 0 | 0 |
| CD22 mediated BCR regulation | R-HSA-5690714 | 9.635436e-01 | 0.016 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 9.635436e-01 | 0.016 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 9.644642e-01 | 0.016 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 9.647846e-01 | 0.016 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 9.651861e-01 | 0.015 | 0 | 0 |
| Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol | R-HSA-193368 | 9.682526e-01 | 0.014 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 9.713639e-01 | 0.013 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 9.718529e-01 | 0.012 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 9.723541e-01 | 0.012 | 0 | 0 |
| Glycosphingolipid catabolism | R-HSA-9840310 | 9.723541e-01 | 0.012 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.736001e-01 | 0.012 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 9.736001e-01 | 0.012 | 0 | 0 |
| Metal ion assimilation from the host | R-HSA-9638482 | 9.736001e-01 | 0.012 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.736001e-01 | 0.012 | 0 | 0 |
| Retinoid metabolism and transport | R-HSA-975634 | 9.736001e-01 | 0.012 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 9.747582e-01 | 0.011 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 9.747900e-01 | 0.011 | 0 | 0 |
| Purine catabolism | R-HSA-74259 | 9.747900e-01 | 0.011 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 9.748281e-01 | 0.011 | 0 | 0 |
| Aspirin ADME | R-HSA-9749641 | 9.759264e-01 | 0.011 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.764645e-01 | 0.010 | 0 | 0 |
| Transport of vitamins, nucleosides, and related molecules | R-HSA-425397 | 9.770116e-01 | 0.010 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 9.808852e-01 | 0.008 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 9.808852e-01 | 0.008 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 9.808852e-01 | 0.008 | 0 | 0 |
| Biosynthesis of DHA-derived SPMs | R-HSA-9018677 | 9.833563e-01 | 0.007 | 0 | 0 |
| Metabolism of fat-soluble vitamins | R-HSA-6806667 | 9.833563e-01 | 0.007 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 9.851879e-01 | 0.006 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 9.867862e-01 | 0.006 | 0 | 0 |
| Sulfur amino acid metabolism | R-HSA-1614635 | 9.873823e-01 | 0.006 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.873823e-01 | 0.006 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 9.893035e-01 | 0.005 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 9.912794e-01 | 0.004 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 9.912794e-01 | 0.004 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.913227e-01 | 0.004 | 0 | 0 |
| Scavenging of heme from plasma | R-HSA-2168880 | 9.924079e-01 | 0.003 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.924461e-01 | 0.003 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.926006e-01 | 0.003 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.927506e-01 | 0.003 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 9.927506e-01 | 0.003 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 9.933905e-01 | 0.003 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 9.936889e-01 | 0.003 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 9.939739e-01 | 0.003 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.941750e-01 | 0.003 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 9.947541e-01 | 0.002 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.956832e-01 | 0.002 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.957192e-01 | 0.002 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 9.960561e-01 | 0.002 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 9.962147e-01 | 0.002 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 9.963759e-01 | 0.002 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.965397e-01 | 0.002 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.967357e-01 | 0.001 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.973783e-01 | 0.001 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.975556e-01 | 0.001 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.976339e-01 | 0.001 | 0 | 0 |
| Glycosphingolipid metabolism | R-HSA-1660662 | 9.981894e-01 | 0.001 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.982713e-01 | 0.001 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.984955e-01 | 0.001 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 9.985022e-01 | 0.001 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.985981e-01 | 0.001 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.985981e-01 | 0.001 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.986744e-01 | 0.001 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 9.986906e-01 | 0.001 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 9.987779e-01 | 0.001 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 9.991611e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 9.992133e-01 | 0.000 | 0 | 0 |
| Biosynthesis of specialized proresolving mediators (SPMs) | R-HSA-9018678 | 9.994043e-01 | 0.000 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.994313e-01 | 0.000 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.995696e-01 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 9.996076e-01 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 9.996176e-01 | 0.000 | 0 | 0 |
| Cytochrome P450 - arranged by substrate type | R-HSA-211897 | 9.998043e-01 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 9.998744e-01 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.999527e-01 | 0.000 | 0 | 0 |
| Infection with Enterobacteria | R-HSA-9640148 | 9.999650e-01 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.999709e-01 | 0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 9.999730e-01 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 9.999939e-01 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 9.999990e-01 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 9.999998e-01 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |